1
|
Hughes GO, Eatherall A, Bird M, Blake J, Branford PR, Gebler S, Lozano A, Massey PA, Reinken G, Terry AS, Whitworth EH. CropLife Europe Crop Development Database: An open-source, pan-European, harmonized crop development database for use in regulatory pesticide exposure modeling and risk assessment. Integr Environ Assess Manag 2023. [PMID: 38054369 DOI: 10.1002/ieam.4870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 11/01/2023] [Accepted: 11/21/2023] [Indexed: 12/07/2023]
Abstract
There is a regulatory need for crop development dates to assess current default values used within chemical exposure assessments as well as to justify refinements within risk assessments. However, a readily available pan-European crop phenology database covering key FOrum for the Co-ordination of pesticide fate models and their USe (FOCUS) crops and scenarios to meet this need is not currently available. Therefore, we describe the development of a harmonized, pan-European, CropLife Europe Crop Development Database (C2D2), that is fully aligned with this regulatory requirement utilizing efficacy trials data generated for regulatory submissions when registering plant protection products under Regulation (EU)1107/2009. Evaluation of C2D2 against an independent data set showed good agreement for equivalent time periods, crop growth stages, and geographical regions. We illustrate how this database can be used to evaluate existing default crop development dates mandated by regulatory agencies for use within exposure assessments. Despite the large data set compiled and the geographical coverage of C2D2, not all FOCUSsw/gw scenarios have sufficient data to facilitate comparison, with less significant scenarios, like FOCUSgw Porto, being underrepresented. For those scenarios with sufficient data, clear differences between C2D2 and crop development dates assumed in the FOCUS modeling framework (using the AppDate tool) are often indicated over many growth stages, suggesting that amendment of the existing representation of crop development within the risk assessment process may be required. C2D2 is freely available under a Creative Commons license to facilitate innovation in exposure science to allow for more accurate and realistic risk assessment leading to enhanced crop and environmental protection. Integr Environ Assess Manag 2023;00:1-15. © 2023 CropLife Europe (Corteva Agriscience) and The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals LLC on behalf of Society of Environmental Toxicology & Chemistry (SETAC).
Collapse
Affiliation(s)
- Gregory O Hughes
- Cambridge Environmental Assessments, Part of RSK ADAS Ltd., Cambridge, UK
- GeoSpatial Analytics Consulting, Mynshull House, Cheshire, UK
| | | | - Michael Bird
- Syngenta Crop Protection AG, Jealott's Hill International Research Centre, Bracknell, Berkshire, UK
| | | | | | | | - Anthony Lozano
- Sumitomo, Parc d'affaires de Crécy, Saint Didier au Mont d'Or, France
| | | | - Gerald Reinken
- Bayer AG, Crop Science Division, Monheim am Rhein, Germany
| | - Adrian S Terry
- Cambridge Environmental Assessments, Part of RSK ADAS Ltd., Cambridge, UK
| | | |
Collapse
|
2
|
Abeloos CH, Gorovets D, Lewis A, Ji W, Lozano A, Tung CC, Yu F, Hanlon A, Lin H, Kha A, Yamada Y, Kabarriti R, Lazarev S, Hasan S, Chhabra AM, Simone CB, Choi IJ. Prospective Evaluation of Patient-Reported Outcomes of Invisible Ink Tattoos for the Delivery of External Beam Radiation Therapy: The PREFER Trial. Int J Radiat Oncol Biol Phys 2023; 117:e234. [PMID: 37784934 DOI: 10.1016/j.ijrobp.2023.06.1152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Invisible ink tattoos allow for setup accuracy while avoiding the cosmetic permanence of visible ink tattoos. The goal of this trial was to evaluate patient-reported preference for the use of invisible ink tattoos in a radiation oncology clinic. MATERIALS/METHODS In an IRB-approved, prospective, feasibility trial, patients at a single institution receiving pencil beam scanning proton therapy to the thorax, abdomen, or pelvis underwent invisible ink tattoo-based treatment setup. Patient preference surveys comparing visible and invisible ink tattoos were completed prior to simulation (17 questions), immediately following simulation (5 questions), and at the end of treatment (18 questions), with preference scored on a 5-point Likert scale from strongly disagree to strongly agree, and cosmesis scored on a 4-point Likert scale of excellent-good-fair-poor. Differences in distributions were examined using Wilcoxon rank-sum tests, Fisher's exact tests, or chi-square tests, where statistical significance was considered at p<0.05. RESULTS Of 107 patients screened, 102 were enrolled and 94 completed all surveys. Mean age was 55.0 years, and 58.5% were female. Most patients were white (79.1%) and non-Hispanic (92.6%). Patients most commonly had breast (34.0%), prostate (16.0%), and lung (9.6%) cancer. An average of 5 (range 3-8) invisible ink tattoos were placed per patient. Overall, 75.5% of patients reported that they would prefer to receive invisible tattoos vs. visible tattoos, and 88.3% rated the overall cosmetic outcome of invisible ink tattoo marks as excellent or good. Compared to males, females were more willing to travel farther from their home in order to avoid receiving visible tattoos (45.4% vs. 23.1%, p = 0.035) and would pay additional money to avoid receiving visible tattoos (34.5% vs. 5.1%, p = 0.002). Patients who had previously received any tattoo (cosmetic or visible RT tattoos) were more satisfied with the appearance of their invisible ink tattoos compared to those who had never previously received tattoos (82.9% vs. 61.5%, p = 0.022). Patients receiving definitive intent RT were more satisfied with the appearance of the tattoos compared to those receiving palliative intent RT (67.1% vs. 38.9%, p = 0.011). Patients with at least a college education were less satisfied with the appearance of tattoos compared to those without a college education (67.0% vs. 95.0% p = 0.018). CONCLUSION These findings demonstrate stronger avoidance of visible tattoos and patient preference for invisible tattoos. The standard incorporation of invisible ink tattoos for patient setup should be strongly considered.
Collapse
Affiliation(s)
| | - D Gorovets
- Memorial Sloan Kettering Cancer Center, New York, NY
| | - A Lewis
- Rutgers Robert Wood Johnson, Newark, NJ
| | - W Ji
- Virginia Tech, Roanoke, VA
| | | | - C C Tung
- New York Proton Center, New York, NY
| | - F Yu
- New York Proton Center, New York, NY
| | | | - H Lin
- New York Proton Center, New York, NY
| | - A Kha
- New York Proton Center, New York, NY
| | - Y Yamada
- Memorial Sloan Kettering Cancer Center, New York, NY
| | - R Kabarriti
- Department of Radiation Oncology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY
| | - S Lazarev
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
| | - S Hasan
- New York Proton Center, New York, NY
| | | | - C B Simone
- Memorial Sloan Kettering Cancer Center, New York, NY; New York Proton Center, New York, NY
| | - I J Choi
- Memorial Sloan Kettering Cancer Center, New York, NY; New York Proton Center, New York, NY
| |
Collapse
|
3
|
Schick J, Lanciano RM, Feng J, Whitlark A, Pancholy P, Ji W, Hanlon A, Lozano A, Lamond J. High Risk Prognostic Factors Predictive of Outcome Following Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Lung Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e55-e56. [PMID: 37785691 DOI: 10.1016/j.ijrobp.2023.06.769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) High risk prognostic factors for outcomes following SBRT for early-stage lung cancer per SWOG/NRG 1914 include: tumor size > 2cm; moderately/poorly/undifferentiated histology; or high metabolic activity on PET/CT defined as SUV > 6.2. The purpose of this IRB approved retrospective study is to assess outcome for stage I lung cancer and to validate SWOG risk stratification in a single community-based radiation department. MATERIALS/METHODS A total of 132 patients with 139 tumors treated with SBRT between 2014 and 2019 were stratified by SWOG risk group (high vs. low). To assess differences by risk group in estimated overall survival (OS) at the patient level, as well as Freedom from Local Failure (FFLF), Freedom from Regional Failure (FFRF) and Freedom from Distant Failure (FFDF) at the tumor level, Kaplan-Meier methodology and Cox proportional hazards (PH) modeling for correlated data were used. Statistical significance was concluded at the 0.05 level. RESULTS Median follow-up for the entire group is 56 months. 77% of patients had high risk tumors. The median patient age was 75 years with 57% female. Patients with high-risk tumors were older (p = 0.023) compared to patients with low-risk tumors. At the tumor level, high risk tumors were more likely to have biopsies performed (91% vs 57% p = 0.002) and more likely to experience regional failure (28% vs 7% p = 0.005). High risk tumors were more likely to experience local failure (8% vs 0% p = NS) and distant failure (27% vs 14% p = NS). Median survival was 49 months for the whole group (46.0 months high risk, 65.1 months low risk). Actuarial OS at 5 years is 38% (35% high risk, 51% low risk). Actuarial FFLF at 5 years is 94% (93% high risk, 100% low risk). Actuarial FFRF at 5 years is 77% (72% high risk, 93% low risk). Actuarial FFDF at 5 years is 74% (70% high risk, 88% low risk). Cox PH models revealed no statistically significant differences in FFRF by risk group (p = 0.08). CONCLUSION Excellent local control but higher regional and distant failure was demonstrated for high-risk lung tumors as defined by SWOG/NRG 1914. Clinically important decrement in outcomes were consistently noted for high-risk tumors in this sample which did not demonstrate statistical significance due to lack of events and statistical power. However, our data supports the prognostic importance of tumor size/grade and SUV for identifying patients at high risk. Further validation with larger sample sizes would contribute to our knowledge regarding risk stratification for early-stage lung cancer treated with SBRT.
Collapse
Affiliation(s)
- J Schick
- Crozer Keystone Healthcare System, Philadelphia, PA
| | - R M Lanciano
- Crozer Keystone Healthcare System/ Philadelphia CyberKnife Center, Havertown, PA
| | - J Feng
- Philadelphia CyberKnife, Havertown, PA
| | - A Whitlark
- Crozer Chester Medical Center, Philadelphia, PA
| | - P Pancholy
- Crozer Chester Medical Center, Philadelphia, PA
| | - W Ji
- Virginia Tech, Roanoke, VA
| | | | | | - J Lamond
- Philadelphia CyberKnife, Philadelphia, PA
| |
Collapse
|
4
|
Ramírez MA, Akhter S, Ahmad Dar Z, Akbar F, Ansari V, Ascencio MV, Sajjad Athar M, Bashyal A, Bellantoni L, Bercellie A, Betancourt M, Bodek A, Bonilla JL, Bravar A, Budd H, Caceres G, Cai T, Díaz GA, da Motta H, Dytman SA, Felix J, Fields L, Filkins A, Fine R, Gallagher H, Ghosh A, Gilligan SM, Gran R, Granados E, Harris DA, Henry S, Jena D, Jena S, Kleykamp J, Klustová A, Kordosky M, Last D, Lozano A, Lu XG, Maher E, Manly S, Mann WA, Mauger C, McFarland KS, Messerly B, Miller J, Moreno O, Morfín JG, Naples D, Nelson JK, Nguyen C, Olivier A, Paolone V, Perdue GN, Plows KJ, Ransome RD, Ruterbories D, Schellman H, Su H, Sultana M, Syrotenko VS, Valencia E, Vaughan NH, Waldron AV, Yaeggy B, Zazueta L. Neutrino-Induced Coherent π^{+} Production in C, CH, Fe, and Pb at ⟨E_{ν}⟩∼6 GeV. Phys Rev Lett 2023; 131:051801. [PMID: 37595210 DOI: 10.1103/physrevlett.131.051801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Revised: 04/07/2023] [Accepted: 06/20/2023] [Indexed: 08/20/2023]
Abstract
MINERvA has measured the ν_{μ}-induced coherent π^{+} cross section simultaneously in hydrocarbon (CH), graphite (C), iron (Fe), and lead (Pb) targets using neutrinos from 2 to 20 GeV. The measurements exceed the predictions of the Rein-Sehgal and Berger-Sehgal PCAC based models at multi-GeV ν_{μ} energies and at produced π^{+} energies and angles, E_{π}>1 GeV and θ_{π}<10°. Measurements of the cross-section ratios of Fe and Pb relative to CH reveal the effective A scaling to increase from an approximate A^{1/3} scaling at few GeV to an A^{2/3} scaling for E_{ν}>10 GeV.
Collapse
Affiliation(s)
- M A Ramírez
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, Mexico
| | - S Akhter
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - Z Ahmad Dar
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - F Akbar
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - V Ansari
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - M V Ascencio
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Peru
| | - M Sajjad Athar
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - A Bashyal
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - L Bellantoni
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bercellie
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M Betancourt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bodek
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - J L Bonilla
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, Mexico
| | - A Bravar
- University of Geneva, 1211 Geneva 4, Switzerland
| | - H Budd
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G Caceres
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - T Cai
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G A Díaz
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H da Motta
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - S A Dytman
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Felix
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, Mexico
| | - L Fields
- Department of Physics, University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Filkins
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - R Fine
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H Gallagher
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - A Ghosh
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida Espańa 1680 Casilla 110-V, Valparaíso, Chile
| | - S M Gilligan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - R Gran
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - E Granados
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, Mexico
| | - D A Harris
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- York University, Department of Physics and Astronomy, Toronto, Ontario, M3J 1P3, Canada
| | - S Henry
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - D Jena
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Jena
- Department of Physical Sciences, IISER Mohali, Knowledge City, SAS Nagar, Mohali - 140306, Punjab, India
| | - J Kleykamp
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A Klustová
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - M Kordosky
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - D Last
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A Lozano
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - X-G Lu
- Department of Physics, University of Warwick, Coventry, CV4 7AL, United Kingdom
- Oxford University, Department of Physics, Oxford, OX1 3PJ, United Kingdom
| | - E Maher
- Massachusetts College of Liberal Arts, 375 Church Street, North Adams, Massachusetts 01247, USA
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - W A Mann
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - C Mauger
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Messerly
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Miller
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida Espańa 1680 Casilla 110-V, Valparaíso, Chile
| | - O Moreno
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, Mexico
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - J G Morfín
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Naples
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J K Nelson
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - C Nguyen
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - A Olivier
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - G N Perdue
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - K-J Plows
- Oxford University, Department of Physics, Oxford, OX1 3PJ, United Kingdom
| | - R D Ransome
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - D Ruterbories
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H Schellman
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - H Su
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Sultana
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V S Syrotenko
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - E Valencia
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, Mexico
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - N H Vaughan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A V Waldron
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - B Yaeggy
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida Espańa 1680 Casilla 110-V, Valparaíso, Chile
| | - L Zazueta
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| |
Collapse
|
5
|
Bercellie A, Kroma-Wiley KA, Akhter S, Ahmad Dar Z, Akbar F, Ansari V, Ascencio MV, Athar MS, Bellantoni L, Betancourt M, Bodek A, Bonilla JL, Bravar A, Budd H, Caceres G, Cai T, Díaz GA, da Motta H, Dytman SA, Felix J, Fields L, Filkins A, Fine R, Gago AM, Gallagher H, Gaur PK, Ghosh A, Gilligan SM, Gran R, Granados E, Harris DA, Jena D, Jena S, Kleykamp J, Klustová A, Kordosky M, Last D, Le T, Lozano A, Lu XG, Mahbub I, Maher E, Manly S, Mann WA, Mauger C, McFarland KS, Messerly B, Miller J, Moreno O, Morfín JG, Naples D, Nelson JK, Nguyen C, Olivier A, Paolone V, Perdue GN, Plows KJ, Ramírez MA, Ransome RD, Ray H, Ruterbories D, Schellman H, Solano Salinas CJ, Su H, Sultana M, Syrotenko VS, Utt B, Valencia E, Vaughan NH, Waldron AV, Yaeggy B, Zazueta L. Simultaneous Measurement of Muon Neutrino ν_{μ} Charged-Current Single π^{+} Production in CH, C, H_{2}O, Fe, and Pb Targets in MINERvA. Phys Rev Lett 2023; 131:011801. [PMID: 37478458 DOI: 10.1103/physrevlett.131.011801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 06/02/2023] [Indexed: 07/23/2023]
Abstract
Neutrino-induced charged-current single π^{+} production in the Δ(1232) resonance region is of considerable interest to accelerator-based neutrino oscillation experiments. In this Letter, high statistic differential cross sections are reported for the semiexclusive reaction ν_{μ}A→μ^{-}π^{+}+ nucleon(s) on scintillator, carbon, water, iron, and lead targets recorded by MINERvA using a wideband ν_{μ} beam with ⟨E_{ν}⟩≈6 GeV. Suppression of the cross section at low Q^{2} and enhancement of low T_{π} are observed in both light and heavy nuclear targets compared with phenomenological models used in current neutrino interaction generators. The cross sections per nucleon for iron and lead compared with CH across the kinematic variables probed are 0.8 and 0.5 respectively, a scaling which is also not predicted by current generators.
Collapse
Affiliation(s)
- A Bercellie
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - K A Kroma-Wiley
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - S Akhter
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - Z Ahmad Dar
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - F Akbar
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - V Ansari
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - M V Ascencio
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | | | - L Bellantoni
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Betancourt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bodek
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - J L Bonilla
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato México
| | - A Bravar
- University of Geneva, 1211 Geneva 4, Switzerland
| | - H Budd
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G Caceres
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - T Cai
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G A Díaz
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H da Motta
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - S A Dytman
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Felix
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato México
| | - L Fields
- Department of Physics, University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Filkins
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - R Fine
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A M Gago
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | - H Gallagher
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - P K Gaur
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - A Ghosh
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - S M Gilligan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - R Gran
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - E Granados
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato México
| | - D A Harris
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- York University, Department of Physics and Astronomy, Toronto, Ontario, M3J 1P3 Canada
| | - D Jena
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Jena
- Department of Physical Sciences, IISER Mohali, Knowledge City, SAS Nagar, Mohali - 140306, Punjab, India
| | - J Kleykamp
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A Klustová
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - M Kordosky
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - D Last
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - T Le
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - A Lozano
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - X-G Lu
- Department of Physics, University of Warwick, Coventry, CV4 7AL, United Kingdom
- Oxford University, Department of Physics, Oxford, OX1 3PJ United Kingdom
| | - I Mahbub
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - E Maher
- Massachusetts College of Liberal Arts, 375 Church Street, North Adams, Massachusetts 01247, USA
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - W A Mann
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - C Mauger
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Messerly
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Miller
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - O Moreno
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato México
| | - J G Morfín
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Naples
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J K Nelson
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - C Nguyen
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - A Olivier
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - G N Perdue
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K-J Plows
- Oxford University, Department of Physics, Oxford, OX1 3PJ United Kingdom
| | - M A Ramírez
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato México
| | - R D Ransome
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - H Ray
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - D Ruterbories
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H Schellman
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - C J Solano Salinas
- Facultad de Ciencias, Universidad Nacional de Ingeniería, Apartado 31139, Lima, Perú
| | - H Su
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Sultana
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V S Syrotenko
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - B Utt
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - E Valencia
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato México
| | - N H Vaughan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A V Waldron
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - B Yaeggy
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - L Zazueta
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| |
Collapse
|
6
|
Kleykamp J, Akhter S, Ahmad Dar Z, Ansari V, Ascencio MV, Sajjad Athar M, Bashyal A, Bercellie A, Betancourt M, Bodek A, Bonilla JL, Bravar A, Budd H, Caceres G, Cai T, Carneiro MF, Díaz GA, da Motta H, Dytman SA, Felix J, Fields L, Filkins A, Fine R, Gago AM, Gallagher H, Gilligan SM, Gran R, Granados E, Harris DA, Henry S, Jena D, Jena S, Klustová A, Kordosky M, Last D, Lozano A, Lu XG, Maher E, Manly S, Mann WA, Mauger C, McFarland KS, Messerly B, Miller J, Moreno O, Morfín JG, Naples D, Nelson JK, Nguyen C, Olivier A, Paolone V, Perdue GN, Plows KJ, Ramírez MA, Ransome RD, Ray H, Ruterbories D, Schellman H, Solano Salinas CJ, Su H, Sultana M, Syrotenko VS, Valencia E, Vaughan NH, Waldron AV, Wret C, Yaeggy B, Zazueta L. Simultaneous Measurement of ν_{μ} Quasielasticlike Cross Sections on CH, C, H_{2}O, Fe, and Pb as a Function of Muon Kinematics at MINERvA. Phys Rev Lett 2023; 130:161801. [PMID: 37154647 DOI: 10.1103/physrevlett.130.161801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2023] [Revised: 03/27/2023] [Accepted: 03/29/2023] [Indexed: 05/10/2023]
Abstract
This Letter presents the first simultaneous measurement of the quasielasticlike neutrino-nucleus cross sections on C, water, Fe, Pb, and scintillator (hydrocarbon or CH) as a function of longitudinal and transverse muon momentum. The ratio of cross sections per nucleon between Pb and CH is always above unity and has a characteristic shape as a function of transverse muon momentum that evolves slowly as a function of longitudinal muon momentum. The ratio is constant versus longitudinal momentum within uncertainties above a longitudinal momentum of 4.5 GeV/c. The cross section ratios to CH for C, water, and Fe remain roughly constant with increasing longitudinal momentum, and the ratios between water or C to CH do not have any significant deviation from unity. Both the overall cross section level and the shape for Pb and Fe as a function of transverse muon momentum are not reproduced by current neutrino event generators. These measurements provide a direct test of nuclear effects in quasielasticlike interactions, which are major contributors to long-baseline neutrino oscillation data samples.
Collapse
Affiliation(s)
- J Kleykamp
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - S Akhter
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - Z Ahmad Dar
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - V Ansari
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - M V Ascencio
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | - M Sajjad Athar
- Department of Physics, Aligarh Muslim University, Aligarh, Uttar Pradesh 202002, India
| | - A Bashyal
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A Bercellie
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M Betancourt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bodek
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - J L Bonilla
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - A Bravar
- University of Geneva, 1211 Geneva 4, Switzerland
| | - H Budd
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G Caceres
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - T Cai
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Department of Physics and Astronomy, York University, Toronto, Ontario M3J 1P3, Canada
| | - M F Carneiro
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - G A Díaz
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H da Motta
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - S A Dytman
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Felix
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - L Fields
- Department of Physics, University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Filkins
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - R Fine
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A M Gago
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | - H Gallagher
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - S M Gilligan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - R Gran
- Department of Physics, University of Minnesota - Duluth, Duluth, Minnesota 55812, USA
| | - E Granados
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - D A Harris
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Department of Physics and Astronomy, York University, Toronto, Ontario M3J 1P3, Canada
| | - S Henry
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - D Jena
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Jena
- Department of Physical Sciences, IISER Mohali, Knowledge City, SAS Nagar, Mohali 140306, Punjab, India
| | - A Klustová
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - M Kordosky
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - D Last
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A Lozano
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - X-G Lu
- Department of Physics, University of Warwick, Coventry CV4 7AL, United Kingdom
- Department of Physics, Oxford University, Oxford OX1 3PJ, United Kingdom
| | - E Maher
- Massachusetts College of Liberal Arts, 375 Church Street, North Adams, Massachusetts 01247, USA
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - W A Mann
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - C Mauger
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Messerly
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Miller
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida Espańa 1680 Casilla 110-V, Valparaíso, Chile
| | - O Moreno
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - J G Morfín
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Naples
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J K Nelson
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| | - C Nguyen
- Department of Physics, University of Florida, Gainesville, Florida 32611, USA
| | - A Olivier
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - G N Perdue
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K-J Plows
- Department of Physics, Oxford University, Oxford OX1 3PJ, United Kingdom
| | - M A Ramírez
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R D Ransome
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - H Ray
- Department of Physics, University of Florida, Gainesville, Florida 32611, USA
| | - D Ruterbories
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H Schellman
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - C J Solano Salinas
- Facultad de Ciencias, Universidad Nacional de Ingeniería, Apartado 31139 Lima, Perú
| | - H Su
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Sultana
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V S Syrotenko
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - E Valencia
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - N H Vaughan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A V Waldron
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
- G. O. Jones Building, Queen Mary University of London, 327 Mile End Road, London E1 4NS, United Kingdom
| | - C Wret
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Yaeggy
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida Espańa 1680 Casilla 110-V, Valparaíso, Chile
| | - L Zazueta
- Department of Physics, William & Mary, Williamsburg, Virginia 23187, USA
| |
Collapse
|
7
|
Lozano A, Souche FR, Chavey C, Dardalhon V, Ramirez C, Vegna S, Desandre G, Riviere A, Zine El Aabidine A, Fort P, Akkari L, Hibner U, Grégoire D. Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma. eLife 2023; 12:76294. [PMID: 36656749 PMCID: PMC9891719 DOI: 10.7554/elife.76294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2021] [Accepted: 01/18/2023] [Indexed: 01/20/2023] Open
Abstract
Quantitative differences in signal transduction are to date an understudied feature of tumour heterogeneity. The MAPK Erk pathway, which is activated in a large proportion of human tumours, is a prototypic example of distinct cell fates being driven by signal intensity. We have used primary hepatocyte precursors transformed with different dosages of an oncogenic form of Ras to model subclonal variations in MAPK signalling. Orthotopic allografts of Ras-transformed cells in immunocompromised mice gave rise to fast-growing aggressive tumours, both at the primary location and in the peritoneal cavity. Fluorescent labelling of cells expressing different oncogene levels, and consequently varying levels of MAPK Erk activation, highlighted the selection processes operating at the two sites of tumour growth. Indeed, significantly higher Ras expression was observed in primary as compared to secondary, metastatic sites, despite the apparent evolutionary trade-off of increased apoptotic death in the liver that correlated with high Ras dosage. Analysis of the immune tumour microenvironment at the two locations suggests that fast peritoneal tumour growth in the immunocompromised setting is abrogated in immunocompetent animals due to efficient antigen presentation by peritoneal dendritic cells. Furthermore, our data indicate that, in contrast to the metastatic-like outgrowth, strong MAPK signalling is required in the primary liver tumours to resist elimination by NK (natural killer) cells. Overall, this study describes a quantitative aspect of tumour heterogeneity and points to a potential vulnerability of a subtype of hepatocellular carcinoma as a function of MAPK Erk signalling intensity.
Collapse
Affiliation(s)
- Anthony Lozano
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Francois-Régis Souche
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
- Department of surgery and liver transplantation, Hopital Saint Eloi Hopitaux universitaires de MontpelierMontpellierFrance
| | - Carine Chavey
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Valérie Dardalhon
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Christel Ramirez
- Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Oncode InstituteAmsterdamNetherlands
| | - Serena Vegna
- Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Oncode InstituteAmsterdamNetherlands
| | - Guillaume Desandre
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Anaïs Riviere
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Amal Zine El Aabidine
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Philippe Fort
- Centre de Recherche en Biologie Cellulaire de Montpellier (CRBM), University of Montpellier, CNRSMontpellierFrance
| | - Leila Akkari
- Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Oncode InstituteAmsterdamNetherlands
| | - Urszula Hibner
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| | - Damien Grégoire
- Institut de Génétique Moléculaire de Montpellier, University of MontpellierMontpellierFrance
| |
Collapse
|
8
|
Choi I, Monteleone A, McCormick B, Sienko D, Lozano A, Xu A, Gillespie E, Braunstein L, LaPlant Q, Cuaron J, Khan A, Powell S, Cahlon O. Reirradiation with Photon Radiotherapy for Recurrent or New Primary Breast Cancer after Prior Breast Irradiation. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.676] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
9
|
Iglesias JA, Benezet Mazuecos J, Crespo B, Esteban I, Lozano A, Crosa J, Miracle A, Jauregui M. Protocolized nurse-guided intravenous conscious sedation for cryoballoon ablation of paroxysmal and persistent atrial fibrillation. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Nursing staff is playing an increasingly important role in arrhythmia units and it entails acquiring more specialized knowledge. Intravenous conscious sedation is being administered more frequently in a wide variety of cardiac procedures including cryoballoon ablation (CBA). Nurses and physicians have distinct yet collaborative roles in the management and care of the patient receiving conscious sedation. It is imperative that the nurse be aware of her/his role in caring for the patient before, during, and after the administration of intravenous conscious sedation.
Purpose
We aimed to evaluate the nurse's role, working in coordination with the medical staff, in intravenous conscious sedation for CBA following a standardized protocol ensuring proper handling and administration of the different drugs, monitorization of vital signs and management of drug infusion in order to avoid pain but also complications inherent to the procedure and sedation.
Method
We included consecutive patients with paroxysmal or persistent AF who underwent a CBA from 2017 to 2021. We evaluated a nurse-guided sedation, under medical surveillance, in CBA procedures using propofol. The dosage was based on the patient's weight, starting sedation with a bolus of 1 ml (1% solution) for every 20 kg of weight, and starting a perfusion at 10 ml/h (2% solution), monitoring constantly patient's vital signs, especially blood pressure and O2saturation. This infusion was adjusted according to the patient's response. During the procedure, on a stable hemodynamic situation, booster bolus of 1 ml (1% solution) could be administered approximately every 15 minutes when needed for sedation. When systolic blood pressure was under 100 mmHg, a solution of midazolam (1mg/ml) and fentanyl (0.05mg/ml) in a mixture of 1cc + 1cc was preferred as booster. Saline and colloid solutions andephedrine (30mg/ml) bolus could be used when severe hypotension to revert propofol's hypotensive effect. Systematic standardized CBA was performed and intraprocedural and periprocedural complications were recorded.
Results
104 patients were included (mean age 58±8 year-old, 85% male). Of these patients, 76 (73%) had recurrent paroxysmal AF, failure of antiarrhythmic drugs was present in 96% and prior radiofrequency ablation in 4%, 61 (59%) showed left atria enlargement (>40 mm or area >20 cm2), and 11 (10%) had structural heart disease. Mean CHA2DS2VASc score was 1. Baseline characteristics in Table 1. Procedural-related complications occurred in 6 patients (5%), transient phrenic nerve palsy in 2 patients and vascular damage in 4. All sedations were performed without complications.
Conclusions
In our experience, protocolized nurse-guided intravenous conscious sedation under medical surveillance in CBA procedures is safe and really useful. It contributes to help medical operators to focus on the procedure sharing the patient's sedation management with trained nurses.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - B Crespo
- La Luz Hospital - Quironsalud , Madrid , Spain
| | - I Esteban
- La Luz Hospital - Quironsalud , Madrid , Spain
| | - A Lozano
- La Luz Hospital - Quironsalud , Madrid , Spain
| | - J Crosa
- La Luz Hospital - Quironsalud , Madrid , Spain
| | - A Miracle
- La Luz Hospital - Quironsalud , Madrid , Spain
| | - M Jauregui
- La Luz Hospital - Quironsalud , Madrid , Spain
| |
Collapse
|
10
|
Ascencio M, Andrade D, Mahbub I, Akhter S, Ahmad Dar Z, Akbar F, Ansari V, Bashyal A, Bender S, Bercellie A, Betancourt M, Bodek A, Bonilla J, Bonin K, Budd H, Caceres G, Cai T, Carneiro M, Díaz G, da Motta H, Felix J, Fields L, Filkins A, Fine R, Fuad N, Gago A, Gallagher H, Gaur P, Ghosh A, Gran R, Haluptzok T, Harris D, Henry S, Jena S, Jena D, Kleykamp J, Klustová A, Kordosky M, Last D, Lozano A, Lu XG, Maher E, Manly S, Mann W, Mauger C, McFarland K, Miller J, Morfín J, Nelson J, Nguyen C, Olivier A, Paolone V, Perdue G, Plows KJ, Ramírez M, Ray H, Reed B, Rodrigues P, Ruterbories D, Sajjad Athar M, Schellman H, Solano Salinas C, Su H, Sultana M, Valencia E, Vaughan N, Waldron A, Wret C, Yaeggy B, Yang K, Zazueta L. Measurement of inclusive charged-current
νμ
scattering on hydrocarbon at
⟨Eν⟩∼6 GeV
with low three-momentum transfer. Int J Clin Exp Med 2022. [DOI: 10.1103/physrevd.106.032001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
11
|
Lozano A, Lujambio A. β-Catenin Is a Novel Target in YES-associated Protein-driven Cholangiocarcinoma. Gastroenterology 2022; 163:374-376. [PMID: 35661722 DOI: 10.1053/j.gastro.2022.05.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2022] [Accepted: 05/25/2022] [Indexed: 12/02/2022]
Affiliation(s)
- Anthony Lozano
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Amaia Lujambio
- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York; Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York; The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, New York; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
| |
Collapse
|
12
|
Ruterbories D, Akhter S, Ahmad Dar Z, Akbar F, Ansari V, Ascencio MV, Sajjad Athar M, Bashyal A, Bercellie A, Betancourt M, Bodek A, Bonilla JL, Bravar A, Budd H, Caceres G, Cai T, Carneiro MF, Díaz GA, da Motta H, Felix J, Fields L, Filkins A, Fine R, Gago AM, Gallagher H, Gaur PK, Ghosh A, Gilligan SM, Gran R, Haase E, Harris DA, Henry S, Jacobsen K, Jena D, Jena S, Kleykamp J, Klustová A, Kordosky M, Last D, Lozano A, Lu XG, Maher E, Manly S, Mann WA, Mauger C, McFarland KS, McGowan AM, Messerly B, Miller J, Moreno O, Morfín JG, Naples D, Nelson JK, Nguyen C, Olivier A, Paolone V, Perdue GN, Plows KJ, Ramírez MA, Ransome RD, Ray H, Schellman H, Solano Salinas CJ, Su H, Sultana M, Syrotenko VS, Valencia E, Vaughan NH, Waldron AV, Wascko MO, Wret C, Yaeggy B, Zazueta L. Simultaneous Measurement of Proton and Lepton Kinematics in Quasielasticlike ν_{μ}-Hydrocarbon Interactions from 2 to 20 GeV. Phys Rev Lett 2022; 129:021803. [PMID: 35867435 DOI: 10.1103/physrevlett.129.021803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Revised: 05/25/2022] [Accepted: 06/21/2022] [Indexed: 06/15/2023]
Abstract
Neutrino charged-current quasielastic-like scattering, a reaction category extensively used in neutrino oscillation measurements, probes nuclear effects that govern neutrino-nucleus interactions. This Letter reports the first measurement of the triple-differential cross section for ν_{μ} quasielastic-like reactions using the hydrocarbon medium of the MINERvA detector exposed to a wideband beam spanning 2≤E_{ν}≤20 GeV. The measurement maps the correlations among transverse and longitudinal muon momenta and summed proton kinetic energies, and compares them to predictions from a state-of-art simulation. Discrepancies are observed that likely reflect shortfalls with modeling of pion and nucleon intranuclear scattering and/or spectator nucleon ejection from struck nuclei. The separate determination of leptonic and hadronic variables can inform experimental approaches to neutrino-energy estimation.
Collapse
Affiliation(s)
- D Ruterbories
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - S Akhter
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - Z Ahmad Dar
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - F Akbar
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - V Ansari
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - M V Ascencio
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761 Lima, Perú
| | | | - A Bashyal
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A Bercellie
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M Betancourt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bodek
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - J L Bonilla
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - A Bravar
- University of Geneva, 1211 Geneva 4, Switzerland
| | - H Budd
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G Caceres
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - T Cai
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M F Carneiro
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - G A Díaz
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H da Motta
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - J Felix
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - L Fields
- Department of Physics, University of Notre Dame, Notre Dame, Indiana 46556, USA
| | - A Filkins
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - R Fine
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A M Gago
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761 Lima, Perú
| | - H Gallagher
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - P K Gaur
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - A Ghosh
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - S M Gilligan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - R Gran
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - E Haase
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - D A Harris
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- York University, Department of Physics and Astronomy, Toronto, Ontario M3J 1P3, Canada
| | - S Henry
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - K Jacobsen
- Department of Physics, University of Minnesota-Duluth, Duluth, Minnesota 55812, USA
| | - D Jena
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Jena
- Department of Physical Sciences, IISER Mohali, Knowledge City, SAS Nagar, Mohali-140306 Punjab, India
| | - J Kleykamp
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A Klustová
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - M Kordosky
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - D Last
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - A Lozano
- Centro Brasileiro de Pesquisas Físicas, Rua Dr. Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro 22290-180, Brazil
| | - X-G Lu
- Department of Physics, University of Warwick, Coventry CV4 7AL, United Kingdom
- Oxford University, Department of Physics, Oxford OX1 3PJ, United Kingdom
| | - E Maher
- Massachusetts College of Liberal Arts, 375 Church Street, North Adams, Massachusetts 01247, USA
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - W A Mann
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - C Mauger
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A M McGowan
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Messerly
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Miller
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - O Moreno
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - J G Morfín
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Naples
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J K Nelson
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| | - C Nguyen
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - A Olivier
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - G N Perdue
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K-J Plows
- Oxford University, Department of Physics, Oxford OX1 3PJ, United Kingdom
| | - M A Ramírez
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - R D Ransome
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - H Ray
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - H Schellman
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - C J Solano Salinas
- Facultad de Ciencias, Universidad Nacional de Ingeniería, Apartado 31139, Lima, Perú
| | - H Su
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Sultana
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V S Syrotenko
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - E Valencia
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana No. 5, Colonia Centro, Guanajuato 36000, Guanajuato, México
| | - N H Vaughan
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A V Waldron
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - M O Wascko
- The Blackett Laboratory, Imperial College London, London SW7 2BW, United Kingdom
| | - C Wret
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Yaeggy
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - L Zazueta
- Department of Physics, William and Mary, Williamsburg, Virginia 23187, USA
| |
Collapse
|
13
|
Arribas L, Hurtós L, González-Tampán A, Taberna M, Vilajosana E, Antonio M, Peiró I, Lozano A, Mesia R. Relationship between body composition changes and EPA supplementation in patients diagnosed with locally advanced squamous cell carcinoma of the head and neck (la-scchn). Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
14
|
Ruterbories D, Ahmad Dar Z, Akbar F, Ascencio M, Bashyal A, Bercellie A, Betancourt M, Bodek A, Bonilla J, Bravar A, Budd H, Caceres G, Cai T, Carneiro M, Díaz G, da Motta H, Felix J, Fields L, Filkins A, Fine R, Gago A, Gallagher H, Ghosh A, Gran R, Harris D, Henry S, Jena D, Jena S, Kleykamp J, Kordosky M, Last D, Le T, Lozano A, Lu XG, Maher E, Manly S, Mann W, Mauger C, McFarland K, McGowan A, Messerly B, Miller J, Morfín J, Naples D, Nelson J, Nguyen C, Norrick A, Olivier A, Paolone V, Perdue G, Plows KJ, Ramírez M, Ray H, Schellman H, Solano Salinas C, Su H, Sultana M, Syrotenko V, Valencia E, Vaughan N, Waldron A, Yaeggy B, Yang K, Zazueta L. Constraining the NuMI neutrino flux using inverse muon decay reactions in MINERvA. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.104.092010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
15
|
Pérez-Montero H, Godino O, Lozano A, Asiáin L, Martínez I, Sánchez JJ, de BlasFernández R, Fernández E, Stefanovic M, García N, Martínez J, Guedea F, Navarro-Martin A. Long-term outcomes of spinal SBRT. Is it important to select the treatment time? Clin Transl Oncol 2021; 24:276-287. [PMID: 34342817 DOI: 10.1007/s12094-021-02684-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Accepted: 07/08/2021] [Indexed: 10/20/2022]
Abstract
PURPOSE SBRT (stereotactic body radiation therapy) is widely used as a curative treatment in tumoral lesions and has become a fundamental tool for the treatment of spine metastasis. In this study, we present survival and toxicity outcomes of spine SBRT after a 2-year follow-up. METHODS/PATIENTS Data from spine SBRT treatments performed at our institution between March 2012 and February 2020 was collected. Medical records, including demographic, primary tumor, and treatment characteristics were reviewed. Patient follow-up included clinical evaluation, imaging, and blood tests. Toxicity was recorded according to CTCAE v4.0. RESULTS We analyzed 73 consecutive spine SBRT treatments in 60 patients. 39.7% of the cases had primary breast cancer and 23.3% had prostate cancer. Most cases (87.7%) were treated with a single SBRT fraction of 16 Gy. Median follow-up was 26.1 months (range 1.7-78.6), and 1- and 2-year overall survival (OS) rates were 96.9% and 84.2%, respectively. Local control (LC) rates at 1- and 2-years were 76.3% and 70.6%, respectively. Multivariate analysis identified histology as a prognostic factor for both OS and LC. Patients who underwent spine SBRT 6 months after the spinal lesion diagnosis had LC at 2 years of 88%, vs 61.7% for those who underwent SBRT before this period. No grade III or higher toxicity was reported. The vertebral compression fracture (VCF) rate was 4.1%. CONCLUSION Spine SBRT at our institution showed a 2-year LC of 70.6%, without G3 toxicities. Delaying SBRT at least 6 months to administer systemic treatment was related to an improvement in local control.
Collapse
Affiliation(s)
- H Pérez-Montero
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - O Godino
- Neurosurgery Department, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - A Lozano
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - L Asiáin
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - I Martínez
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - J J Sánchez
- Radiodiagnostic Department, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - R de BlasFernández
- Medical Physics and Radiation Protection Department, Institut Català D'Oncologia, Barcelona, Spain
| | - E Fernández
- Physical Medicine and Rehabilitation Department, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - M Stefanovic
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - N García
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - J Martínez
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - F Guedea
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain
| | - A Navarro-Martin
- Radiation Oncology Department, Institut Català D'Oncologia, Barcelona, Spain.
| |
Collapse
|
16
|
Linares Galiana I, Garcia Exposito N, Plana M, Brenes J, Oliva M, Nogues J, Cos M, Rodriguez L, Tornero J, Mora P, Lozano A. PO-0960 Long-term outcome of IMRT-SIB and chemotherapy in nasopharyngeal carcinoma in a nonendemic area. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07411-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
17
|
Ordas L, Costa L, Lozano A, Chevillard C, Calovoulos A, Kantar D, Fernandez L, Chauvin L, Dosset P, Doucet C, Heron-Milhavet L, Odintsova E, Berditchevski F, Milhiet PE, Bénistant C. Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1. Cells 2021; 10:cells10061545. [PMID: 34207462 PMCID: PMC8234748 DOI: 10.3390/cells10061545] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2021] [Revised: 06/10/2021] [Accepted: 06/15/2021] [Indexed: 01/16/2023] Open
Abstract
The plasma membrane is a key actor of cell migration. For instance, its tension controls persistent cell migration and cell surface caveolae integrity. Then, caveolae constituents such as caveolin-1 can initiate a mechanotransduction loop that involves actin- and focal adhesion-dependent control of the mechanosensor YAP to finely tune cell migration. Tetraspanin CD82 (also named KAI-1) is an integral membrane protein and a metastasis suppressor. Its expression is lost in many cancers including breast cancer. It is a strong inhibitor of cell migration by a little-known mechanism. We demonstrated here that CD82 controls persistent 2D migration of EGF-induced single cells, stress fibers and focal adhesion sizes and dynamics. Mechanistically, we found that CD82 regulates membrane tension, cell surface caveolae abundance and YAP nuclear translocation in a caveolin-1-dependent manner. Altogether, our data show that CD82 controls 2D cell migration using membrane-driven mechanics involving caveolin and the YAP pathway.
Collapse
Affiliation(s)
- Laura Ordas
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
| | - Luca Costa
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
| | - Anthony Lozano
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
- Institut de Génétique Moléculaire de Montpellier, University Montpellier, CNRS, 34293 Montpellier, France
| | - Christopher Chevillard
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
| | - Alexia Calovoulos
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
| | - Diala Kantar
- Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194—University Montpellier—Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France; (D.K.); (L.H.-M.)
| | - Laurent Fernandez
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
- European Institute of Chemistry and Biology (IECB), University of Bordeaux, 33607 Pessac, France
| | - Lucie Chauvin
- Centre de Recherche de Biologie Cellulaire de Montpellier (CRBM), CNRS UMR 5237, University Montpellier, 34293 Montpellier, France;
| | - Patrice Dosset
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
| | - Christine Doucet
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
| | - Lisa Heron-Milhavet
- Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U1194—University Montpellier—Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France; (D.K.); (L.H.-M.)
| | - Elena Odintsova
- Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; (E.O.); (F.B.)
| | - Fedor Berditchevski
- Institute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; (E.O.); (F.B.)
| | - Pierre-Emmanuel Milhiet
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
- Correspondence: (P.-E.M.); (C.B.)
| | - Christine Bénistant
- Centre de Biologie Structurale (CBS), CNRS, INSERM, University Montpellier, 34090 Montpellier, France; (L.O.); (L.C.); (A.L.); (C.C.); (A.C.); (L.F.); (P.D.); (C.D.)
- Correspondence: (P.-E.M.); (C.B.)
| |
Collapse
|
18
|
Arechederra M, Bazai SK, Abdouni A, Sequera C, Mead TJ, Richelme S, Daian F, Audebert S, Dono R, Lozano A, Gregoire D, Hibner U, Allende DS, Apte SS, Maina F. ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma. J Hepatol 2021; 74:893-906. [PMID: 33197513 DOI: 10.1016/j.jhep.2020.11.008] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Revised: 10/29/2020] [Accepted: 11/02/2020] [Indexed: 02/07/2023]
Abstract
BACKGROUND & AIMS The tumour microenvironment shapes tumour growth through cellular communications that include both direct interactions and secreted factors. The aim of this study was to characterize the impact of the secreted glycoprotein ADAMTSL5, whose role in cancer has not been previously investigated, on hepatocellular carcinoma (HCC). METHODS ADAMTSL5 methylation status was evaluated through bisulfite sequencing, and publicly available data analysis. ADAMTSL5 RNA and protein expression were assessed in mouse models and HCC patient samples and compared to data from published datasets. Functional studies, including association of ADAMTSL5 depletion with responsiveness to clinically relevant drugs, were performed in cellular and in vivo models. Molecular alterations associated with ADAMTSL5 targeting were determined using proteomics, biochemistry, and reverse-transcription quantitative PCR. RESULTS Methylome analysis revealed hypermethylated gene body CpG islands at the ADAMTSL5 locus in both mouse and human HCC, correlating with higher ADAMTSL5 expression. ADAMTSL5 targeting interfered with tumorigenic properties of HCC cells in vitro and in vivo, whereas ADAMTSL5 overexpression conferred tumorigenicity to pre-tumoural hepatocytes sensitized to transformation by a modest level of MET receptor expression. Mechanistically, ADAMTSL5 abrogation led to a reduction of several oncogenic inputs relevant to HCC, including reduced expression and/or phosphorylation levels of receptor tyrosine kinases MET, EGFR, PDGFRβ, IGF1Rβ, or FGFR4. This phenotype was associated with significantly increased sensitivity of HCC cells to clinically relevant drugs, namely sorafenib, lenvatinib, and regorafenib. Moreover, ADAMTSL5 depletion drastically increased expression of AXL, accompanied by a sensitization to bemcentinib. CONCLUSIONS Our results point to a role for ADAMTSL5 in maintaining the function of key oncogenic signalling pathways, suggesting that it may act as a master regulator of tumorigenicity and drug resistance in HCC. LAY SUMMARY The environment of cancer cells has profound effects on establishment, progression, and response of a tumour to treatment. Herein, we show that ADAMTSL5, a protein secreted by liver cancer cells and overlooked in cancer so far, is increased in this tumour type, is necessary for tumour formation and supports drug resistance. Adamtsl5 removal conferred sensitivity of liver cancer cells to drugs used in current treatment. This suggests ADAMTSL5 as a potential marker in liver cancer as well as a possible drug target.
Collapse
Affiliation(s)
- Maria Arechederra
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Sehrish K Bazai
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Ahmed Abdouni
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Celia Sequera
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Timothy J Mead
- Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, 44195, USA
| | - Sylvie Richelme
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Fabrice Daian
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Stéphane Audebert
- Aix-Marseille Univ, CRCM, Marseille Proteomics, INSERM, CNRS, Institut Paoli-Calmettes, Marseille, France
| | - Rosanna Dono
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France
| | - Anthony Lozano
- Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France
| | - Damien Gregoire
- Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France
| | - Urszula Hibner
- Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France
| | - Daniela S Allende
- Pathology Department, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, 44195, USA
| | - Suneel S Apte
- Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH, 44195, USA
| | - Flavio Maina
- Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), UMR7288, Parc Scientifique de Luminy, Marseille, France.
| |
Collapse
|
19
|
Lozano A, Marruecos J, Rubió J, Farré N, Gómez-Millán J, Morera R, Planas I, Lanzuela M, Vázquez-Masedo MG, Cascallar L, Giralt J, Escames G, Valentí V, Grima P, Bosser R, Tarragó C, Mesía R. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment. Clin Transl Oncol 2021; 23:1801-1810. [PMID: 33738704 DOI: 10.1007/s12094-021-02586-w] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Accepted: 03/06/2021] [Indexed: 01/04/2023]
Abstract
PURPOSE The objective of this trial was to evaluate the safety and efficacy of melatonin oral gel mouthwashes in the prevention and treatment of oral mucositis (OM) in patients treated with concurrent radiation and systemic treatment for head and neck cancer. METHODS Randomized, phase II, double-blind, placebo-controlled trial (1:1 ratio) of 3% melatonin oral gel mouthwashes vs. placebo, during IMRT (total dose ≥ 66 Gy) plus concurrent Q3W cisplatin or cetuximab. Primary endpoint: grade 3-4 OM or Severe Oral Mucositis (SOM) incidence by RTOG, NCI, and a composite RTOG-NCI scales. Secondary endpoints: SOM duration and grade 2-4 OM or Ulcerative Oral Mucositis (UOM) incidence and duration. RESULTS Eighty-four patients were included in the study. Concurrent systemic treatments were cisplatin (n = 54; 64%) or cetuximab (n = 30; 36%). Compared with the placebo arm, RTOG-defined SOM incidence was numerically lower in the 3% melatonin oral gel arm (53 vs. 64%, P = 0.36). In patients treated with cisplatin, assessed by the RTOG-NCI composite scale, both SOM incidence (44 vs. 78%; P = 0.02) and median SOM duration (0 vs. 22 days; P = 0.022) were significantly reduced in the melatonin arm. Median UOM duration assessed by the RTOG-NCI scale was also significantly shorter in the melatonin arm (49 vs. 73 days; P = 0.014). Rate of adverse events and overall response rate were similar between the two arms. CONCLUSIONS Treatment with melatonin oral gel showed a consistent trend to lower incidence and shorter SOM duration and shorter duration of UOM. These results warrant further investigation in phase III clinical trial.
Collapse
Affiliation(s)
- A Lozano
- Institut Català d'Oncologia (ICO), Hospital Durán I Reynals, Avda de la Granvia de l'Hospitalet, 199, L'Hospitalet, 08907, Barcelona, Spain.
| | - J Marruecos
- Institut Català d'Oncologia (ICO), Hospital Universitari Dr. Josep Trueta, Avda França s/n, 17007, Girona, Spain
| | - J Rubió
- Institut Català d'Oncologia (ICO), Hospital Universitari Dr. Josep Trueta, Avda França s/n, 17007, Girona, Spain
| | - N Farré
- Hospital de la Santa Creu i Sant Pau, C/Sant Quintí, 89, 08041, Barcelona, Spain
| | - J Gómez-Millán
- Hospital Universitario Virgen de la Victoria, Campus de Teatinos, s/n, 29010, Málaga, Spain
| | - R Morera
- Hospital Universitario la Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain
| | - I Planas
- Institut Català d'Oncologia (ICO), Hospital Germans Trias i Pujol, Carretera de Canyet, s/n, Badalona, 08916, Barcelona, Spain
| | - M Lanzuela
- Hospital Universitario Miguel Servet, Paseo Isabel la Católica, 1-3, 50009, Zaragoza, Spain
| | - M G Vázquez-Masedo
- Hospital Clínico San Carlos, C/Profesor Martín Lagos, s/n, 28040, Madrid, Spain
| | - L Cascallar
- Hospital Clínico Universitario de Santiago, CHUS, Rúa da Choupana, s/n, Santiago de Compostela, 15706, A Coruña, Spain
| | - J Giralt
- Hospital Universitari de la Vall d'Hebron, Passeig de la Vall d'Hebron, 119, 08035, Barcelona, Spain
| | - G Escames
- Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada Hospital Complex, 18016, Granada, Spain.,Department of Physiology, University of Granada, CIBERFES, IBS, Granada Hospital Complex, 18016, Granada, Spain
| | - V Valentí
- Hospital de Sant Pau i Santa Tecla, C/ Rambla Vella, 14, 43003, Tarragona, Spain
| | - P Grima
- Ferrer Internacional SA, Avenida Diagonal, 549, 08029, Barcelona, Spain
| | - R Bosser
- Spherium Biomed, S.L.U., C/ Joan XXIII, 10, 08950, Esplugues de Llobregat, Spain
| | - C Tarragó
- Ferrer Internacional SA, Avenida Diagonal, 549, 08029, Barcelona, Spain.,Spherium Biomed, S.L.U., C/ Joan XXIII, 10, 08950, Esplugues de Llobregat, Spain
| | - R Mesía
- Institut Català d'Oncologia (ICO), Hospital Durán I Reynals, Avda de la Granvia de l'Hospitalet, 199, L'Hospitalet, 08907, Barcelona, Spain.,Institut Català d'Oncologia (ICO), Hospital Germans Trias i Pujol, Carretera de Canyet, s/n, Badalona, 08916, Barcelona, Spain
| |
Collapse
|
20
|
Rodríguez-Lozano FJ, López-García S, García-Bernal D, Sanz JL, Lozano A, Pecci-Lloret MP, Melo M, López-Ginés C, Forner L. Cytocompatibility and bioactive properties of the new dual-curing resin-modified calcium silicate-based material for vital pulp therapy. Clin Oral Investig 2021; 25:5009-5024. [PMID: 33638052 DOI: 10.1007/s00784-021-03811-0] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2020] [Accepted: 01/22/2021] [Indexed: 01/03/2023]
Abstract
OBJECTIVE The aim of the present study was to evaluate the in vitro biocompatibility of Theracal PT, Theracal LC, and MTA Angelus, considered as bioactive materials used for vital pulp treatment, on human dental pulp stem cells (hDPSCs). MATERIALS AND METHODS Human dental pulp stem cells (hDPSCs) were isolated from third molars, and material eluates were prepared (undiluted, 1:2, and 1:4 ratios). The hDPSC cytotoxicity, adhesion, morphology, viability, and cell migration were assessed. The mineralization nodule formation was determined by Alizarin red S staining (ARS). The odonto/osteogenic differentiation potential was assessed by osteo/odontogenic marker expression real-time qPCR. The chemical composition and ion release of the vital pulp materials were determined by energy dispersive X-ray (EDX) and inductively coupled plasma-mass spectrometry (ICP-MS), respectively. Statistical differences were assessed by ANOVA and Tukey's test (p < 0.05). RESULTS The three vital pulp materials showed variable levels of calcium, tungsten, silicon, and zirconium release and in their chemical composition. Cytocompatibility assays revealed higher hDPSC viability and migration rates when treated with Theracal PT than with Theracal LC. The lowest cell adhesion and spreading were observed in all Theracal LC-treated groups, whereas the highest were observed when treated with MTA. Theracal PT and MTA promoted the upregulation of DSPP and RUNX2 gene expression (p < 0.05). After 21 days, both MTA Angelus and Theracal PT-treated cells exhibited a significantly higher mineralized nodule formation than the negative control (p < 0.05). CONCLUSIONS This study demonstrates the favorable in vitro cytocompatibility and bioactive properties of the recently introduced Theracal PT and the well-established MTA Angelus on hDPSCs, as opposed to Theracal LC. More studies, including in vivo animal testing are suggested before these new formulations might be used in the clinical setting. CLINICAL RELEVANCE Theracal PT is a new material that could be clinically suitable for vital pulp therapy. Further studies considering its biocompatibility and bioactivity are necessary.
Collapse
Affiliation(s)
- Francisco Javier Rodríguez-Lozano
- Cellular Therapy and Hematopoietic Transplant Research Group, Biomedical Research Institute, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, University of Murcia, 30120, Murcia, Spain.
- Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain.
- School of Dentistry, Hospital Morales Meseguer 2 pl., University of Murcia, Av. Marqués de los Vélez, s/n, 30008, Murcia, Spain.
| | - S López-García
- Cellular Therapy and Hematopoietic Transplant Research Group, Biomedical Research Institute, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, University of Murcia, 30120, Murcia, Spain
- Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain
| | - D García-Bernal
- Cellular Therapy and Hematopoietic Transplant Research Group, Biomedical Research Institute, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, University of Murcia, 30120, Murcia, Spain
| | - J L Sanz
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - A Lozano
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - M P Pecci-Lloret
- Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain
| | - M Melo
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - C López-Ginés
- Department of Pathology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - L Forner
- Cellular Therapy and Hematopoietic Transplant Research Group, Biomedical Research Institute, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, University of Murcia, 30120, Murcia, Spain
| |
Collapse
|
21
|
Querol JM, Rubió-Casadevall J, Lozano A, Buxó M, Linares I, Planas I, Vayreda J, Cirauqui B, Taberna M, Quiroga V, Tobed M, Bores T, Saigi M, Felip E, Recalde S, Eraso A, Mesia R. PO-0815: Validation of a Prognostic Model for Predicting Larynx Preservation Outcome in Catalan Population. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00832-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
Llop S, Sanz MT, Plana M, Oliva M, Brenes J, Honorato M, Gomez V, Nogués J, Mesía R, Lozano A, Antonio M. 936P Outcome and toxicity in older patients with locoregionally-advanced head and neck cancer: Relevance of an oncogeriatric approach. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
23
|
Sanz JL, López-García S, Lozano A, Pecci-Lloret MP, Llena C, Guerrero-Gironés J, Rodríguez-Lozano FJ, Forner L. Microstructural composition, ion release, and bioactive potential of new premixed calcium silicate-based endodontic sealers indicated for warm vertical compaction technique. Clin Oral Investig 2020; 25:1451-1462. [PMID: 32651645 DOI: 10.1007/s00784-020-03453-8] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Accepted: 07/07/2020] [Indexed: 12/17/2022]
Abstract
OBJECTIVE The aim of this study was to evaluate the microstructural composition, ion release, cytocompatibility, and mineralization potential of Bio-C Sealer ION+ (BCI) and EndoSequence BC Sealer HiFlow (BCHiF), compared with AH Plus (AHP), in contact with human periodontal ligament cells (hPDLCs). MATERIALS AND METHODS The sealers' ionic composition and release were assessed using energy-dispersive spectroscopy (EDS) and inductively coupled plasma mass spectrometry (ICP-MS), respectively. For the biological assays, hPDLCs were isolated from third molars, and sealer extracts were prepared (undiluted, 1:2, and 1:4 ratios). An MTT assay, wound-healing assay, and cell morphology and adhesion analysis were performed. Activity-related gene expression was determined using RT-qPCR, and mineralization potential was assessed using Alizarin Red staining (ARS). Statistical analyses were performed using one-way ANOVA and Tukey's post hoc test (α < 0.05). RESULTS The three sealers exhibited variable levels of silicon, calcium, zirconium, and tungsten release and in their composition. Both BCI and BCHiF groups showed positive results in cytocompatibility assays, unlike AHP. The BCHiF group showed an upregulation of CAP (p < 0.01), CEMP1, ALP, and RUNX2 (p < 0.001) compared with the negative control, while the BCI group showed an upregulation of CEMP1 (p < 0.01), CAP, and RUNX2 (p < 0.001). Both groups also exhibited a greater mineralization potential than the negative and positive controls (p < 0.001). CONCLUSIONS The calcium silicate-based sealers considered in the present in vitro study exhibited a high calcium ion release, adequate cytocompatibility, upregulated osteo/cementogenic gene expression, and increased mineralized nodule formation in contact with hPDLCs. CLINICAL RELEVANCE From a biological perspective, BCI and BCHiF could be clinically suitable for root canal filling.
Collapse
Affiliation(s)
- J L Sanz
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - S López-García
- Cellular Therapy and Hematopoietic Transplant Research Group, Biomedical Research Institute, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, University of Murcia, 30120, Murcia, Spain.,Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain
| | - A Lozano
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - M P Pecci-Lloret
- Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain
| | - C Llena
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| | - J Guerrero-Gironés
- Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain
| | - F J Rodríguez-Lozano
- Cellular Therapy and Hematopoietic Transplant Research Group, Biomedical Research Institute, Virgen de la Arrixaca Clinical University Hospital, IMIB-Arrixaca, University of Murcia, 30120, Murcia, Spain. .,Department of Dermatology, Stomatology, Radiology and Physical Medicine, Morales Meseguer Hospital, Faculty of Medicine, University of Murcia, 30100, Murcia, Spain.
| | - L Forner
- Department of Stomatology, Faculty of Medicine and Dentistry, Universitat de València, 46010, Valencia, Spain
| |
Collapse
|
24
|
Rodríguez‐Lozano FJ, López‐García S, García‐Bernal D, Tomás‐Catalá CJ, Santos JM, Llena C, Lozano A, Murcia L, Forner L. Chemical composition and bioactivity potential of the new Endosequence BC Sealer formulation HiFlow. Int Endod J 2020; 53:1216-1228. [DOI: 10.1111/iej.13327] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2019] [Accepted: 05/08/2020] [Indexed: 12/21/2022]
Affiliation(s)
- F. J. Rodríguez‐Lozano
- Biomedical Research Institute of Murcia‐Arrixaca Cellular Therapy and Hematopoietic Transplant Unit IMIB‐Arrixaca University of Murcia MurciaSpain
- Gerodontology and Special Care in Dentistry Unit. School of Dentistry Faculty of Medicine University of Murcia Murcia Spain
| | - S. López‐García
- Biomedical Research Institute of Murcia‐Arrixaca Cellular Therapy and Hematopoietic Transplant Unit IMIB‐Arrixaca University of Murcia MurciaSpain
| | - D. García‐Bernal
- Biomedical Research Institute of Murcia‐Arrixaca Cellular Therapy and Hematopoietic Transplant Unit IMIB‐Arrixaca University of Murcia MurciaSpain
| | - C. J. Tomás‐Catalá
- Biomedical Research Institute of Murcia‐Arrixaca Cellular Therapy and Hematopoietic Transplant Unit IMIB‐Arrixaca University of Murcia MurciaSpain
- Gerodontology and Special Care in Dentistry Unit. School of Dentistry Faculty of Medicine University of Murcia Murcia Spain
| | - J. M. Santos
- Institute of Endodontics Faculty of Medicine University of Coimbra Coimbra Portugal
| | - C. Llena
- Department of Stomatology University de Valencia ValenciaSpain
| | - A. Lozano
- Department of Stomatology University de Valencia ValenciaSpain
| | - L. Murcia
- Department of Genetics and Microbiology University of Murcia Murcia Spain
| | - L. Forner
- Department of Stomatology University de Valencia ValenciaSpain
| |
Collapse
|
25
|
Richards KC, Vallabhaneni V, Moelter S, Davis EM, Morrison J, Lozano A, Hanlon A, Wang Y, Wolk D, Gooneratne N. 0861 Age, Race, And Continuous Positive Airway Pressure (CPAP) Confidence Score At 1-week Predict 3-month CPAP Adherence In Older Adults With Amnestic Mild Cognitive Impairment And Moderate To Severe Obstructive Sleep Apnea. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Adherence to continuous positive airway pressure (CPAP) may delay cognitive decline in older adults with obstructive sleep apnea (OSA) and amnestic mild cognitive impairment (MCI), defined as deficits in memory that do not significantly impact daily functioning. The aim of this analysis was to identify predictors of CPAP adherence in this population.
Methods
Data are from Memories 2, an ongoing multisite clinical trial on the effect of treatment of moderate to severe OSA on cognitive decline in older adults 65-85 years of age who have amnestic MCI. Unadjusted and adjusted linear models were used to examine predictors of mean hours of CPAP use at 3 months. Predictors were age, sex (male/female), race (White/Non-White), education (more than high school, less than high school), Apnea-hypopnea index (AHI), Epworth Sleepiness Scale (ESS), and CPAP Comfort and Confidence scores at 7 days. Collinearity in the adjusted model for CPAP use at 3 months was examined using the variance inflation factor.
Results
Of 57 participants, most were male (54%), White (72%), with a mean age of 66.3 years (SD: 6.1). Mean AHI in this sample was 35.1 (SD: 19.9), with mean daily hours of CPAP use at 3 months 5.3 hours (SD: 2.3). Adjusted linear model results demonstrated that younger age (β=-0.13, SE=0.04, p=0.0032), White race (β=2.56, SE=0.58, p<0.0001), and higher 7-day CPAP Confidence score (β=0.48, SE=0.17, p=0.0086) were significantly associated with CPAP use at 3 months. Sex, education, AHI, ESS, and CPAP comfort were not statistically significant predictors of adherence.
Conclusion
Tailored interventions to increase self-efficacy during the first 7 days of CPAP treatment, especially in Non-Whites and those older than 74 years, may improve long-term CPAP adherence in older adults with amnestic MCI.
Support
R01AG054435
Collapse
Affiliation(s)
| | - V Vallabhaneni
- Sleep 360 Diagnostic Center, Austin, TX
- Texas A&M University, College Station, TX
| | - S Moelter
- University of the Sciences, Philadelphia, PA
| | - E M Davis
- University of Virginia, Charlottesville, VA
| | - J Morrison
- University of Texas at Austin, Austin, TX
| | | | | | - Y Wang
- University of Texas at Austin, Austin, TX
| | - D Wolk
- University of Pennsylvania, Philadelphia, PA
| | | |
Collapse
|
26
|
Wang Y, Fomenko A, Nankoo J, Tran S, Zeng K, Drummond N, Lozano A, Chen R. P205 Inhibitory effects of low-intensity focused ultrasound stimulation on the contralateral primary motor cortex. Clin Neurophysiol 2020. [DOI: 10.1016/j.clinph.2019.12.316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
27
|
Carneiro MF, Ruterbories D, Ahmad Dar Z, Akbar F, Andrade DA, Ascencio MV, Badgett W, Bashyal A, Bercellie A, Betancourt M, Bonin K, Bravar A, Budd H, Caceres G, Cai T, da Motta H, Díaz GA, Felix J, Fields L, Filkins A, Fine R, Gago AM, Ghosh A, Gran R, Hahn D, Harris DA, Henry S, Hylen J, Jena S, Jena D, Joe C, King B, Kleykamp J, Kordosky M, Last D, Le T, LeClerc J, Lozano A, Lu XG, Maher E, Manly S, Mann WA, McFarland KS, McGivern CL, McGowan AM, Messerly B, Miller J, Morfín JG, Murphy M, Naples D, Nelson JK, Nguyen C, Norrick A, Olivier A, Paolone V, Perdue GN, Riehecky P, Schellman H, Schlabach P, Solano Salinas CJ, Su H, Sultana M, Syrotenko VS, Torretta D, Wret C, Yaeggy B, Yonehara K, Zazueta L. High-Statistics Measurement of Neutrino Quasielasticlike Scattering at 6 GeV on a Hydrocarbon Target. Phys Rev Lett 2020; 124:121801. [PMID: 32281855 DOI: 10.1103/physrevlett.124.121801] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Revised: 02/01/2020] [Accepted: 02/05/2020] [Indexed: 06/11/2023]
Abstract
We measure neutrino charged-current quasielasticlike scattering on hydrocarbon at high statistics using the wideband Neutrinos at the Main Injector beam with neutrino energy peaked at 6 GeV. The double-differential cross section is reported in terms of muon longitudinal (p_{∥}) and transverse (p_{⊥}) momentum. Cross section contours versus lepton momentum components are approximately described by a conventional generator-based simulation, however, discrepancies are observed for transverse momenta above 0.5 GeV/c for longitudinal momentum ranges 3-5 and 9-20 GeV/c. The single differential cross section versus momentum transfer squared (dσ/dQ_{QE}^{2}) is measured over a four-decade range of Q^{2} that extends to 10 GeV^{2}. The cross section turnover and falloff in the Q^{2} range 0.3-10 GeV^{2} is not fully reproduced by generator predictions that rely on dipole form factors. Our measurement probes the axial-vector content of the hadronic current and complements the electromagnetic form factor data obtained using electron-nucleon elastic scattering. These results help oscillation experiments because they probe the importance of various correlations and final-state interaction effects within the nucleus, which have different effects on the visible energy in detectors.
Collapse
Affiliation(s)
- M F Carneiro
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
- Centro Brasileiro de Pesquisas Físicas, Rua Doutor Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - D Ruterbories
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - Z Ahmad Dar
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - F Akbar
- AMU Campus, Aligarh, Uttar Pradesh 202001, India
| | - D A Andrade
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana 5, Colonia Centro, Guanajuato 36000, Mexico
| | - M V Ascencio
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | - W Badgett
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Bashyal
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - A Bercellie
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M Betancourt
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - K Bonin
- Department of Physics, University of Minnesota Duluth, Duluth, Minnesota 55812, USA
| | - A Bravar
- Département de Physique Nucléaire et Corpusculaire, University of Geneva, 1211 Geneva 4, Switzerland
| | - H Budd
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - G Caceres
- Centro Brasileiro de Pesquisas Físicas, Rua Doutor Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - T Cai
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - H da Motta
- Centro Brasileiro de Pesquisas Físicas, Rua Doutor Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - G A Díaz
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | - J Felix
- Campus León y Campus Guanajuato, Universidad de Guanajuato, Lascurain de Retana 5, Colonia Centro, Guanajuato 36000, Mexico
| | - L Fields
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - A Filkins
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - R Fine
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - A M Gago
- Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Apartado 1761, Lima, Perú
| | - A Ghosh
- Centro Brasileiro de Pesquisas Físicas, Rua Doutor Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - R Gran
- Department of Physics, University of Minnesota Duluth, Duluth, Minnesota 55812, USA
| | - D Hahn
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D A Harris
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Department of Physics and Astronomy, Toronto, Ontario, M3J 1P3 Canada
| | - S Henry
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - J Hylen
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - S Jena
- Department of Physical Sciences, IISER Mohali, Knowledge City, SAS Nagar, Mohali 140306, Punjab, India
| | - D Jena
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Joe
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - B King
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - J Kleykamp
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - M Kordosky
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - D Last
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - T Le
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
- Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA
| | - J LeClerc
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - A Lozano
- Centro Brasileiro de Pesquisas Físicas, Rua Doutor Xavier Sigaud 150, Urca, Rio de Janeiro, Rio de Janeiro, 22290-180, Brazil
| | - X-G Lu
- Oxford University, Department of Physics, Oxford OX1 3PJ, United Kingdom
| | - E Maher
- Department of Physics, Massachusetts College of Liberal Arts, 375 Church Street, North Adams, Massachusetts 01247, USA
| | - S Manly
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - W A Mann
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - K S McFarland
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - C L McGivern
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - A M McGowan
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Messerly
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J Miller
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - J G Morfín
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - M Murphy
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - D Naples
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - J K Nelson
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - C Nguyen
- University of Florida, Department of Physics, Gainesville, Florida 32611, USA
| | - A Norrick
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| | - A Olivier
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V Paolone
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - G N Perdue
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - P Riehecky
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - H Schellman
- Department of Physics, Oregon State University, Corvallis, Oregon 97331, USA
| | - P Schlabach
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C J Solano Salinas
- Facultad de Ciencias, Universidad Nacional de Ingeniería, Apartado 31139, Lima, Perú
| | - H Su
- Department of Physics and Astronomy, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
| | - M Sultana
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - V S Syrotenko
- Physics Department, Tufts University, Medford, Massachusetts 02155, USA
| | - D Torretta
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - C Wret
- Department of Physics and Astronomy, University of Rochester, Rochester, New York 14627, USA
| | - B Yaeggy
- Departamento de Física, Universidad Técnica Federico Santa María, Avenida España 1680 Casilla 110-V, Valparaíso, Chile
| | - K Yonehara
- Fermi National Accelerator Laboratory, Batavia, Illinois 60510, USA
| | - L Zazueta
- Department of Physics, College of William & Mary, Williamsburg, Virginia 23187, USA
| |
Collapse
|
28
|
Valero J, Peleteiro P, Henríquez I, Conde A, Piquer T, Lozano A, Soler CC, Muñoz J, Illescas A, Jove J, Flores MM, Baquedano J, Diezhandino P, de Celis RP, Pardo EH, Samper P, Villoslada I, Eguiguren M, Millan V. Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR). Clin Transl Oncol 2020; 22:1378-1389. [PMID: 31989474 DOI: 10.1007/s12094-019-02274-w] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2019] [Accepted: 12/16/2019] [Indexed: 12/14/2022]
Abstract
INTRODUCTION The treatment of metastatic castration-resistant prostate cancer (mCRPC) has changed significantly in recent years. Inhibitors of androgen receptors have shown especially significant benefits in overall (OS) and progression-free survival (PFS), with a good toxicity profile. Treatment selection depends on the patient's individual clinical, radiological, and biological characteristics. OBJECTIVE To describe treatment outcomes (efficacy, toxicity) in a cohort of patients with mCRPC in Spain. MATERIALS AND METHODS Multicenter, retrospective study of patients with mCRPC included in a database of the Urological Tumour Working Group (URONCOR) of the Spanish Society of Radiation Oncology (SEOR). Metastatic CRPC was defined according to the prostate cancer working group 3 (PCWG3) criteria. The Kaplan-Meier technique was used to evaluate OS and the Common Terminology Criteria for Adverse Events (CTCAE, v.4.0) were used to assess toxicity. Univariate and multivariate Cox regression analyses were performed to identify the factors significantly associated with OS. RESULTS A total of 314 patients from 17 hospitals in Spain diagnosed with mCRPC between June 2010 and September 2017 were included in this study. Mean age at diagnosis was 68 years (range 45-89). At a median follow-up of 35 months, OS at 1, 3, and 5 years were 92%, 38%, and 28%, respectively. Grades 1-2 and grade 3 toxicity rates were, respectively, 68% and 19%. No grade 4 toxicities were observed. On the multivariate analysis, the following factors were significantly associated with OS: age (hazard ratio [HR] 0.42, p = 0.010), PSA value at diagnosis of mCRPC (HR 0.55, p = 0.008), and Gleason score (HR 0.61, p = 0.009). CONCLUSIONS Age, Gleason score, and PSA at diagnosis of mCRPC are independently associated with overall survival in patients with mCRPC. The efficacy and toxicity outcomes in this patient cohort treated in radiation oncology departments in Spain are consistent with previous reports.
Collapse
Affiliation(s)
- J Valero
- Hospital Universitario HM Sanchinarro, Madrid, Spain.
| | - P Peleteiro
- Hospital Clinico Universitario de Santiago de Compostela, Santiago, Spain
| | - I Henríquez
- Hospital Universitario Sant Joan de Reus, Tarragona, Spain
| | - A Conde
- Hospital La Fe de Valencia, Valencia, Spain
| | - T Piquer
- Hospital de Castellon, Castellón, Spain
| | - A Lozano
- Hospital Virgen de la Arrixaca de Murcia, El Palmar, Spain
| | - C C Soler
- Hospital Torrecardenas Almeria, Almería, Spain
| | - J Muñoz
- Hospital Universitario Infanta Cristina de Badajoz, Badajoz, Spain
| | - A Illescas
- Hospital Virgen de la Macarena de Sevilla, Sevilla, Spain
| | - J Jove
- Instituto Catalan de Oncologia Badalona, Barcelona, Spain
| | - M M Flores
- Hospital Universitario Arnau de Vilanova, Lleida, Spain
| | - J Baquedano
- Hospital Universitario Arnau de Vilanova, Lleida, Spain
| | - P Diezhandino
- Hospital Clinico Universitario de Valladolid, Valladolid, Spain
| | - R P de Celis
- Hospital Txagorritxu de Vitoria, Vitoria-Gasteiz, Spain
| | - E H Pardo
- Hospital Txagorritxu de Vitoria, Vitoria-Gasteiz, Spain
| | - P Samper
- Hospital Universitario Rey Juan Carlos de Mostoles, Madrid, Spain
| | | | - M Eguiguren
- Hospital Universitario Donostia, Donostia-San Sebastian, Spain
| | - V Millan
- Hospital Clinico Universitario de Zaragoza, Zaragoza, Spain
| |
Collapse
|
29
|
Anstey JR, Taccone FS, Udy AA, Citerio G, Duranteau J, Ichai C, Badenes R, Prowle JR, Ercole A, Oddo M, Schneider AG, van der Jagt M, Wolf S, Helbok R, Nelson DW, Skrifvars MB, Harrois A, Presneill J, Cooper DJ, Bailey M, Bellomo R, Long K, Lozano A, Saxby E, Vargiolu A, Rodrigues A, Quintard H, Del Rio M, Sisson A, Allen G, Baro N, Kofler M. Early Osmotherapy in Severe Traumatic Brain Injury: An International Multicenter Study. J Neurotrauma 2020; 37:178-184. [DOI: 10.1089/neu.2019.6399] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- James R. Anstey
- Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - Fabio S. Taccone
- Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium
| | - Andrew A. Udy
- Intensive Care Unit, The Alfred Hospital, Melbourne, Victoria, Australia
- Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
| | - Giuseppe Citerio
- School of Medicine and Surgery, University Milano Bicocca–Neurointensive Care, San Gerardo Hospital, ASST-Monza, Monza, Italy
| | - Jacques Duranteau
- Department of Anesthesia and Surgical Intensive Care, CHU de Bicetre, Le Kremlin Bicêtre, Le Kremlin-Bicêtre, France
| | - Carole Ichai
- Université Côte d'Azur, Centre hospitalier Universitaire de Nice, Service de Réanimation polyvalente, Hôpital Pasteur 2, CHU de Nice, Nice, France
| | - Rafael Badenes
- Department of Anesthesiology and Surgical-Trauma Intensive Care, Hospital Clinic Universitari de Valencia, University of Valencia, Valencia, Spain
| | - John R. Prowle
- Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust, Royal London Hospital, Whitechapel Road, London, United Kingdom
| | - Ari Ercole
- Neurosciences and Trauma Critical Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
| | - Mauro Oddo
- Department of Medical-Surgical Intensive Care Medicine, Faculty of Biology and Medicine, Centre Hospitalier Universitaire, Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland
| | - Antoine G. Schneider
- Department of Medical-Surgical Intensive Care Medicine, Faculty of Biology and Medicine, Centre Hospitalier Universitaire, Vaudois (CHUV), University of Lausanne, Lausanne, Switzerland
| | - Mathieu van der Jagt
- Department of Intensive Care, Erasmus MC-University Medical Centre, Erasmus MC–University Medical Center, Rotterdam, The Netherlands
| | - Stefan Wolf
- Department of Neurosurgery, Charité Universitätsmedizin Neuro Intensive Care Unit 102i, Campus Charité Mitte (CCM), Berlin, Germany
| | - Raimund Helbok
- Neurological Intensive Care Unit, Department of Neurology, Medical University of Innsbruck, Department of Neurology, Neurocritical Care Unit, Innsbruck, Austria
| | - David W. Nelson
- Section for Perioperative Medicine and Intensive Care, Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden
| | - Marius B. Skrifvars
- Division of Intensive Care, Department of Anaesthesiology, Intensive Care and Pain Medicine and Department of Emergency Medicine and Services, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - Anatole Harrois
- Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
- Department of Anesthesia and Surgical Intensive Care, CHU de Bicetre, Le Kremlin Bicêtre, Le Kremlin-Bicêtre, France
| | - Jeffrey Presneill
- Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
| | - D. Jamie Cooper
- Intensive Care Unit, The Alfred Hospital, Melbourne, Victoria, Australia
- Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
| | - Michael Bailey
- Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
- Department of Medicine and Radiology, University of Melbourne, Parkville, Victoria, Australia
| | - Rinaldo Bellomo
- Intensive Care Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia
- Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, ANZIC-RC, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
- Department of Intensive Care, Austin Health, Melbourne, Victoria, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Adame JA, Notario A, Cuevas CA, Lozano A, Yela M, Saiz-Lopez A. Recent increase in NO 2 levels in the southeast of the Iberian Peninsula. Sci Total Environ 2019; 693:133587. [PMID: 31369892 DOI: 10.1016/j.scitotenv.2019.133587] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/06/2019] [Revised: 07/09/2019] [Accepted: 07/23/2019] [Indexed: 06/10/2023]
Abstract
We report the evolution of tropospheric NO2 over the south-east of the Iberian Peninsula from 2005 to 2017. We have used hourly NO2 levels measured at air-quality stations in urban and suburban environments. Annual averages ranged between 14 and 45 μg m-3, with peaks above 200 μg m-3. A monthly variation was observed, with higher concentrations in cold months (40-60 μg m-3) and lower levels in the warm season (13-17 μg m-3). A diurnal pattern was found in urban and suburban areas. The upward trend in NO2 observed during the whole period contrasts with the upward trend reported in 2013-2017. The NO2 tropospheric column levels measured by the Ozone Monitoring Instrument over the Iberian Peninsula indicated a similar behaviour; nevertheless, the largest Spanish metropolitan areas did not show this increase. The mean sea level pressure and wind field data of ERA5 (European Centre for Medium-Range Weather Forecasts) were used to investigate the weather conditions, the NO2 outputs of the Copernicus Monitoring Services being used for the assessment of the NO2 spatial distribution. NO2 regional events, with concentrations in the range 140-150 μg m-3, and which occurred both in the winter and summer season under anticyclonic conditions, are also described. A local origin is identified in winter, whereas in summer, they are associated with a high-pressure system that blocks Mediterranean outflows towards the Atlantic Ocean. The high NO2 levels are attributed mainly to two factors: i) local emissions, rather than contributions from the western Mediterranean (or even North Africa), and ii) an increase in the pressure gradient between the Atlantic and the Mediterranean pressure systems, associated with a decrease in wind speed, was found during the last five years compared with the previous eight. Meteorological and chemical changes in mid-latitudes associated with global warming should also be investigated in the future.
Collapse
Affiliation(s)
- J A Adame
- Atmospheric Sounding Station, El Arenosillo Observatory, Atmospheric Research and Instrumentation Branch, National Institute for Aerospace Technology (INTA), Mazagón, Huelva, Spain.
| | - A Notario
- Universidad de Castilla-La Mancha, Departamento de Química Física, Facultad de Ciencias y Tecnologías Químicas, Ciudad Real, Spain; Universidad de Castilla-La Mancha, Instituto de Investigación en Combustión y Contaminación Atmosférica, Camino de Moledores s/n, Ciudad Real, Spain
| | - C A Cuevas
- Department of Atmospheric Chemistry and Climate, Institute of Physical Chemistry Rocasolano, CSIC, Madrid, Spain
| | - A Lozano
- Agencia de Medio Ambiente y Agua de Andalucía, Seville, Spain
| | - M Yela
- Atmospheric Sounding Station, El Arenosillo Observatory, Atmospheric Research and Instrumentation Branch, National Institute for Aerospace Technology (INTA), Mazagón, Huelva, Spain
| | - A Saiz-Lopez
- Department of Atmospheric Chemistry and Climate, Institute of Physical Chemistry Rocasolano, CSIC, Madrid, Spain
| |
Collapse
|
31
|
de Mendoza C, Roc L, Fernández‐Alonso M, Soriano V, Rodríguez C, Vera M, del Romero J, Marcaida G, Ocete M, Caballero E, Molina I, Aguilera A, Rodríguez‐Calviño J, Navarro D, Rivero C, Vilariño M, Benito R, Algarate S, Gil J, Ortiz de Lejarazu R, Rojo S, Eirós J, San Miguel A, Manzardo C, Miró J, García J, Paz I, Poveda E, Calderón E, Escudero D, Trigo M, Diz J, García‐Campello M, Rodríguez‐Iglesias M, Hernández‐Betancor A, Martín A, Ramos J, Gimeno A, Gutiérrez F, Rodríguez J, Sánchez V, Gómez‐Hernando C, Cilla G, Pérez‐Trallero E, López‐Aldeguer J, Fernández‐Pereira L, Niubó J, Hernández M, López‐Lirola A, Gómez‐Sirvent J, Force L, Cifuentes C, Pérez S, Morano L, Raya C, González‐Praetorius A, Pérez J, Peñaranda M, Hernáez‐Crespo S, Montejo J, Roc L, Martínez‐Sapiña A, Viciana I, Cabezas T, Lozano A, Fernández J, García‐Bermejo I, Gaspar G, García R, Górgolas M, Vegas C, Blas J, Miralles P, Valeiro M, Aldamiz T, Margall N, Guardia C, do Pico E, Polo I, Aguinaga A, Ezpeleta C, Sauleda S, Pirón M, González R, Barea L, Jiménez A, Blanco L, Suárez A, Rodríguez‐Avial I, Pérez‐Rivilla A, Parra P, Fernández M, Fernández‐Alonso M, Treviño A, Requena S, Benítez‐Gutiérrez L, Cuervas‐Mons V, de Mendoza C, Barreiro P, Soriano V, Corral O, Gómez‐Gallego F. HTLV testing of solid organ transplant donors. Clin Transplant 2019; 33:e13670. [DOI: 10.1111/ctr.13670] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2019] [Revised: 07/06/2019] [Accepted: 07/08/2019] [Indexed: 11/27/2022]
Affiliation(s)
- Carmen de Mendoza
- Internal Medicine Laboratory Puerta de Hierro Research Institute & University Hospital Madrid Spain
- Microbiology section, Pharmaceutical and Health Science Department Pablo-CEU University Madrid Spain
| | - Lourdes Roc
- Microbiology Department Hospital Miguel Servet Zaragoza Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Martinez Trufero J, Mesia Nin R, Ortega Izquierdo M, Lozano A, Cirauqui Cirauqui B, Rubió Casadevall J, Taberna Sanz M, Pastor Borgoñon M, Lambea Sorrosal J, Iglesias L, Vázquez S, del Barco Morillo E, Perez Segura P, Lopez Pousa A, Ponce J, Cruz-Hernández J. Final results of a phase II study of induction chemotherapy (CT) with paclitaxel (PTX) and panitumumab (P) followed by radiotherapy (RT) and P in patients (pts) with locally advanced head and neck cancer (LAHNC) no candidates to platinum: Study PANTERA. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz252.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
33
|
Nieva M, Fabregat C, Tous S, Mena M, Teulé A, Lozano A, León X, Guix M, Bonfill T, Mesía R, Alemany L, Taberna M. Real-world data of clinicopathologic characteristics of young oropharyngeal cancer patients. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz252.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Roshkovan L, Lozano A, Hanlon A, Jain V, Cengel K, Li CS, Berman A, Feigenberg S, Katz S. P2.01-65 Temporal Changes of Radiation-Induced Lung Injury Following Proton Therapy for Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
35
|
Palacios R, Mayorga M, González-Domenech CM, Hidalgo-Tenorio C, Gálvez C, Muñoz-Medina L, de la Torre J, Lozano A, Castaño M, Omar M, Santos J. Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study. J Int Assoc Provid AIDS Care 2019. [PMID: 29529910 PMCID: PMC6748491 DOI: 10.1177/2325958218760847] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Objectives: To analyze the efficacy and safety of dolutegravir/rilpivirine (DTG/RPV) in HIV-infected patients who switched from any other antiretroviral therapy (ART). Methods: Open-label, multicenter study including patients who switched to DTG/RPV between February 2015 and February 2016. Efficacy (HIV RNA <50 copies/mL), adverse events, and metabolic changes at 24 weeks were analyzed. Results: A total of 104 participants were included, who switched for the following reasons: toxicity/intolerance (42.3%), convenience (27.8%), and drug interactions (17.3%). Prior regimens are protease inhibitor (56.7%), integrase strand transfer inhibitor (26.9%), and non-nucleoside reverse transcriptase inhibitor (16.3%). Efficacy at 24 weeks was 88.4% (intention to treat) and 96.8% (per protocol). Triglyceride levels were reduced, on average, by 12.7% and a mean decrease of 9.0% in the glomerular filtration rate was observed as well (P values of .003 and .002, respectively), whereas total cholesterol, HDL cholesterol, LDL cholesterol, creatinine, and glutamic-pyruvic transaminase remained unchanged. No patient discontinued due to adverse events. Conclusions: Dolutegravir/RPV is effective and safe in long-term HIV-infected patients under any prior ART. Toxicity, convenience, and interactions were the main reasons for changing. At 24 weeks, the lipid profile improved with a decrease in triglycerides.
Collapse
Affiliation(s)
- Rosario Palacios
- 1 UGC Enfermedades Infecciosas y Microbiología, Hospital Virgen de la Victoria, Málaga, Spain
| | - M Mayorga
- 2 UGC Enfermedades Infecciosas y Microbiología, Hospital Carlos Haya, Málaga, Spain
| | - C M González-Domenech
- 1 UGC Enfermedades Infecciosas y Microbiología, Hospital Virgen de la Victoria, Málaga, Spain
| | - C Hidalgo-Tenorio
- 3 Servicio de Enfermedades Infecciosas, Complejo Hospitalario Universitario Granada, Granada, Spain
| | - C Gálvez
- 4 UGC Enfermedades Infecciosas, Hospital Torrecárdenas, Málaga, Spain
| | - L Muñoz-Medina
- 3 Servicio de Enfermedades Infecciosas, Complejo Hospitalario Universitario Granada, Granada, Spain
| | - J de la Torre
- 5 UGC Enfermedades Infecciosas, Hospital Costa del Sol, Málaga, Spain
| | - A Lozano
- 6 UGC Enfermedades Infecciosas, Hospital de Poniente, Almería, Spain
| | - M Castaño
- 2 UGC Enfermedades Infecciosas y Microbiología, Hospital Carlos Haya, Málaga, Spain
| | - M Omar
- 7 UGC Enfermedades Infecciosas, Complejo hospitalario de Jaén, Jaén, Spain
| | - Jesús Santos
- 1 UGC Enfermedades Infecciosas y Microbiología, Hospital Virgen de la Victoria, Málaga, Spain
| |
Collapse
|
36
|
Arribas L, Sabaté A, Taberna M, Hurtós L, González-Tampán A, Peiró I, Sospedra M, Vilajosana E, Lozano A, Virgili N, Mesia R, Baracos V. SUN-PO112: Nutritional and Body Composition Changes During Radical Treatment for Locally Advanced Head and Neck Cancer (LA-HNC) Patients. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32746-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
37
|
López-García S, Myong-Hyun B, Lozano A, García-Bernal D, Forner L, Llena C, Guerrero-Gironés J, Murcia L, Rodríguez-Lozano FJ. Cytocompatibility, bioactivity potential, and ion release of three premixed calcium silicate-based sealers. Clin Oral Investig 2019; 24:1749-1759. [DOI: 10.1007/s00784-019-03036-2] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2019] [Accepted: 07/18/2019] [Indexed: 12/11/2022]
|
38
|
Garcia-Rill E, Saper CB, Rye DB, Kofler M, Nonnekes J, Lozano A, Valls-Solé J, Hallett M. Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA. Clin Neurophysiol 2019; 130:925-940. [PMID: 30981899 PMCID: PMC7365492 DOI: 10.1016/j.clinph.2019.03.008] [Citation(s) in RCA: 39] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Revised: 03/15/2019] [Accepted: 03/22/2019] [Indexed: 12/12/2022]
Abstract
The pedunculopontine nucleus (PPN) is located in the mesopontine tegmentum and is best delimited by a group of large cholinergic neurons adjacent to the decussation of the superior cerebellar peduncle. This part of the brain, populated by many other neuronal groups, is a crossroads for many important functions. Good evidence relates the PPN to control of reflex reactions, sleep-wake cycles, posture and gait. However, the precise role of the PPN in all these functions has been controversial and there still are uncertainties in the functional anatomy and physiology of the nucleus. It is difficult to grasp the extent of the influence of the PPN, not only because of its varied functions and projections, but also because of the controversies arising from them. One controversy is its relationship to the mesencephalic locomotor region (MLR). In this regard, the PPN has become a new target for deep brain stimulation (DBS) for the treatment of parkinsonian gait disorders, including freezing of gait. This review is intended to indicate what is currently known, shed some light on the controversies that have arisen, and to provide a framework for future research.
Collapse
Affiliation(s)
- E Garcia-Rill
- Center for Translational Neuroscience, Department of Neurobiology and Developmental Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
| | - C B Saper
- Department of Neurology, Division of Sleep Medicine and Program in Neuroscience, Harvard Medical School, Boston, MA, USA
| | - David B Rye
- Department of Neurology, Division of Sleep Medicine and Program in Neuroscience, Harvard Medical School, Boston, MA, USA
| | - M Kofler
- Department of Neurology, Hochzirl Hospital, Zirl, Austria
| | - J Nonnekes
- Radboud University Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Department of Rehabilitation, Nijmegen, the Netherlands
| | - A Lozano
- Division of Neurosurgery, University of Toronto and Krembil Neuroscience Centre, University Health Network, Toronto, Canada
| | - J Valls-Solé
- Neurology Department, Hospital Clínic, University of Barcelona, IDIBAPS (Institut d'Investigació Biomèdica August Pi i Sunyer), Barcelona, Spain
| | - M Hallett
- Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
39
|
Linares I, Taberna M, Nogués J, Mesía R, Najjari D, Mases J, Guix I, Plana M, Lozano A. EP-1148 Long-term outcome of IMRT with simultaneous integrated boost in nasopharyngeal carcinoma. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31568-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
40
|
Rodríguez‐Lozano FJ, Collado‐González M, López‐García S, García‐Bernal D, Moraleda JM, Lozano A, Forner L, Murcia L, Oñate‐Sánchez RE. Evaluation of changes in ion release and biological properties of NeoMTA‐Plus and Endocem‐MTA exposed to an acidic environment. Int Endod J 2019; 52:1196-1209. [DOI: 10.1111/iej.13107] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2018] [Accepted: 02/28/2019] [Indexed: 12/27/2022]
Affiliation(s)
- F. J. Rodríguez‐Lozano
- Cellular Therapy and Hematopoietic Transplant Unit Hematology Department Virgen de la Arrixaca Clinical University Hospital IMIB‐Arrixaca University of Murcia Murcia Spain
- Special Care in Dentistry and Gerodontology Faculty of Medicine School of Dentistry University of Murcia Murcia Spain
| | - M. Collado‐González
- Cellular Therapy and Hematopoietic Transplant Unit Hematology Department Virgen de la Arrixaca Clinical University Hospital IMIB‐Arrixaca University of Murcia Murcia Spain
- Special Care in Dentistry and Gerodontology Faculty of Medicine School of Dentistry University of Murcia Murcia Spain
| | - S. López‐García
- Cellular Therapy and Hematopoietic Transplant Unit Hematology Department Virgen de la Arrixaca Clinical University Hospital IMIB‐Arrixaca University of Murcia Murcia Spain
| | - D. García‐Bernal
- Cellular Therapy and Hematopoietic Transplant Unit Hematology Department Virgen de la Arrixaca Clinical University Hospital IMIB‐Arrixaca University of Murcia Murcia Spain
- Department of Internal Medicine University of Murcia Murcia Spain
| | - J. M. Moraleda
- Cellular Therapy and Hematopoietic Transplant Unit Hematology Department Virgen de la Arrixaca Clinical University Hospital IMIB‐Arrixaca University of Murcia Murcia Spain
- Department of Internal Medicine University of Murcia Murcia Spain
| | - A. Lozano
- Department of Stomatology. Clínica Odontológica Universitat de València Valencia Spain
| | - L. Forner
- Department of Stomatology. Clínica Odontológica Universitat de València Valencia Spain
| | - L. Murcia
- Department of Genetics and Microbiology University of Murcia Murcia Spain
| | - R. E. Oñate‐Sánchez
- Special Care in Dentistry and Gerodontology Faculty of Medicine School of Dentistry University of Murcia Murcia Spain
| |
Collapse
|
41
|
Cortés-Rodríguez B, Alférez-Reyes M, Castro P, Casasola R, Sánchez F, Lozano A. [Influence of frequent users of the emergency departments on unscheduled revisits]. J Healthc Qual Res 2019; 34:157-158. [PMID: 30878343 DOI: 10.1016/j.jhqr.2019.01.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Accepted: 01/02/2019] [Indexed: 11/15/2022]
Affiliation(s)
- B Cortés-Rodríguez
- Servicio de Medicina Interna, Hospital Alto Guadalquivir, Andújar, España
| | - M Alférez-Reyes
- Servicio de Gestoría del Usuario, Hospital de Alta Resolución de Puente Genil, Puente Genil, España
| | - P Castro
- Servicio de Urgencias, Hospital de Alta Resolución de Puente Genil, Puente Genil, España
| | - R Casasola
- Servicio de Gestoría del Usuario, Hospital de Alta Resolución de Puente Genil, Puente Genil, España
| | - F Sánchez
- Servicio de Urgencias, Hospital de Alta Resolución de Puente Genil, Puente Genil, España
| | - A Lozano
- Servicio de Medicina Interna, Hospital Alto Guadalquivir, Andújar, España.
| |
Collapse
|
42
|
Linares I, Taberna M, Nogués J, Mesia R, Najjari D, Mases J, Guix I, Plana M, Lozano A. PO-077 Long-term outcome of IMRT with simultaneous integrated boost in nasopharyngeal carcinoma. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30243-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
43
|
Lozano A, Hernando M, Uclés S, Hakme E, Fernández-Alba A. Identification and measurement of veterinary drug residues in beehive products. Food Chem 2019; 274:61-70. [DOI: 10.1016/j.foodchem.2018.08.055] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Revised: 07/12/2018] [Accepted: 08/12/2018] [Indexed: 10/28/2022]
|
44
|
Marín J, Oliva Bernal M, Plana Serrahima M, Ferrer M, Vilariño Quintela N, Vazquez S, Vilajosana E, Lozano A, Nogués J, Marí A, Bermejo O, Mesia Nin R, Taberna Sanz M. Paclitaxel in combination with anti-EGFR therapy as induction chemotherapy for patients unfit for cisplatin with locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy287.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
45
|
Suárez B, Lozano A, Díaz A, Ortega X, Diaz J, Calcagno G, Hervias C, Bevilacqua J, Castiglioni C. INFLAMMATORY MYOPATHIES. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Taberna M, Torres M, Alejo M, Mena M, Tous S, Marquez S, Pavon M, Leon X, Garcia J, Guix M, Hijano R, Bonfill T, Aguilà A, Lozano A, Mesia Nin R, Alemany L, Bravo I. The use of HPV16-E5, EGFR and pEGFR as prognostic biomarkers for oropharyngeal cancer patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy287.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Hakme E, Lozano A, Uclés S, Gómez-Ramos M, Fernández-Alba A. High-throughput gas chromatography-mass spectrometry analysis of pesticide residues in spices by using the enhanced matrix removal-lipid and the sample dilution approach. J Chromatogr A 2018; 1573:28-41. [DOI: 10.1016/j.chroma.2018.08.046] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Revised: 08/16/2018] [Accepted: 08/21/2018] [Indexed: 10/28/2022]
|
48
|
Hakme E, Lozano A, Ferrer C, Díaz-Galiano F, Fernández-Alba A. Analysis of pesticide residues in olive oil and other vegetable oils. Trends Analyt Chem 2018. [DOI: 10.1016/j.trac.2017.12.016] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
49
|
Gonzalez C, Forner L, Llena C, Lozano A. Temperature changes in 2% chlorhexidine gluconate using
two activation methods with different intensity levels. J Clin Exp Dent 2018; 10:e458-e461. [PMID: 29849970 PMCID: PMC5971069 DOI: 10.4317/jced.54732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2018] [Accepted: 03/14/2018] [Indexed: 11/19/2022] Open
Abstract
Background Chlorhexidine is an irrigant solution widely used in root canal treatment because of its good antimicrobial properties. However, its mixture with sodium hypochlorite results in the appearance of substance called p-chloroaniline, a cytotoxic substance. This is also found when chlorhexidine is heated. The use of passive ultrasonic irrigation is related to an irrigant thermal increase, which can cause the appearance of p-chloroaniline. Thus, the objective is to establish the influence of ultrasonic and sonic activation, with the use of different intensities, upon the temperature of chlorhexidine gluconate (CHX). Material and Methods The following groups were established: control (without activation), ultrasonic activation and sonic activation. A 0.5-ml volume of CHX was placed in an Eppendorf tube in a thermo-static bath at 37ºC. Both methods resulted in immediate CHX activation. The temperature was recorded every 30 seconds between 60 and 180 seconds. The statistical analysis was performed based on the Mann-Whitney U-test. Results Both groups subjected to activation showed higher temperatures than the control group, and increased activation intensity was associated to greater temperature increments in both activated groups. Conclusions Both ultrasonic and sonic activation are correlated to temperature increase in CHX. Key words:Chlorhexidine, p-choroaniline, PUI, sonic irrigation, temperature.
Collapse
|
50
|
Tomás-Catalá CJ, Collado-González M, García-Bernal D, Oñate-Sánchez RE, Forner L, Llena C, Lozano A, Castelo-Baz P, Moraleda JM, Rodríguez-Lozano FJ. Comparative analysis of the biological effects of the endodontic bioactive cements MTA-Angelus, MTA Repair HP and NeoMTA Plus on human dental pulp stem cells. Int Endod J 2017; 50 Suppl 2:e63-e72. [DOI: 10.1111/iej.12859] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2017] [Accepted: 09/05/2017] [Indexed: 02/06/2023]
Affiliation(s)
- C. J. Tomás-Catalá
- Cellular Therapy and Hematopoietic Transplant Unit; Hematology Department; Virgen de la Arrixaca Clinical University Hospital; IMIB-Arrixaca; University of Murcia; Murcia Spain
- Faculty of Medicine; School of Dentistry; University of Murcia; Murcia Spain
| | - M. Collado-González
- Cellular Therapy and Hematopoietic Transplant Unit; Hematology Department; Virgen de la Arrixaca Clinical University Hospital; IMIB-Arrixaca; University of Murcia; Murcia Spain
| | - D. García-Bernal
- Cellular Therapy and Hematopoietic Transplant Unit; Hematology Department; Virgen de la Arrixaca Clinical University Hospital; IMIB-Arrixaca; University of Murcia; Murcia Spain
| | - R. E. Oñate-Sánchez
- Faculty of Medicine; School of Dentistry; University of Murcia; Murcia Spain
| | - L. Forner
- Department of Stomatology; University de Valencia; Valencia Spain
| | - C. Llena
- Department of Stomatology; University de Valencia; Valencia Spain
| | - A. Lozano
- Department of Stomatology; University de Valencia; Valencia Spain
| | - P. Castelo-Baz
- University of Santiago de Compostela; Santiago de Compostela Spain
| | - J. M. Moraleda
- Cellular Therapy and Hematopoietic Transplant Unit; Hematology Department; Virgen de la Arrixaca Clinical University Hospital; IMIB-Arrixaca; University of Murcia; Murcia Spain
| | - F. J. Rodríguez-Lozano
- Cellular Therapy and Hematopoietic Transplant Unit; Hematology Department; Virgen de la Arrixaca Clinical University Hospital; IMIB-Arrixaca; University of Murcia; Murcia Spain
- Faculty of Medicine; School of Dentistry; University of Murcia; Murcia Spain
| |
Collapse
|